NewzIntel.com

Category: COVID-19 Vaccine

  • MIL-OSI Submissions: GAZA – Israeli UNRWA ban will deepen Palestinian humanitarian catastrophe – MSF

    Source: Médecins Sans Frontières/Doctors Without Borders (MSF)

    30 October, 2024. The Israeli Knesset’s ban on UNRWA’s operations voted on 28 October represents a devastating blow to Palestinian life. It will further undermine people’s survival prospects in Gaza and heavily impact communities in the West Bank.

    Médecins Sans Frontières/Doctors Without Borders (MSF) denounces this legislation, which represents an inhumane ban on vital humanitarian aid. The Knesset’s vote is propelling Palestinians towards an even deeper humanitarian crisis. It is imperative that the world acts to safeguard Palestinians’ fundamental rights. Immediate international intervention is needed to pressure Israel to allow unhindered access to humanitarian aid, implement a ceasefire and bring to an end the current campaign of destruction in Gaza.

    “UNRWA is a lifeline for Palestinians,” says Christopher Lockyear, MSF Secretary General. “If implemented, the ban on UNRWA’s activities would have catastrophic implications on the dire humanitarian situation of Palestinians living in Gaza, as well as in the West Bank, now and for generations to come. We strongly condemn this decision, which is the culmination of a long-running campaign against the organisation.”

    The newly voted legislation will make it almost impossible for UNRWA to work in Gaza or the West Bank; coordination with Israeli authorities will be impeded and entrance permits to either of the occupied territories will be denied, and essentially blocking delivery of UNRWA aid into and within Gaza. UNRWA handles almost all the distribution of UN aid coming into the strip.

    UNRWA is the largest health provider in Gaza, with over half of Gazans relying on UNWRA for essential healthcare services, including for the treatment of chronic diseases, maternal and child heath, and vaccinations; each day UNWRA’s health teams provide over 15,000 consultations in the Gaza Strip. The ban of its activities threatens to create a vast gap in services within an already largely destroyed health system in Gaza – directly and indirectly endangering the lives of Palestinians. Without urgent action, more Gazans could die from preventable diseases and displacement-related conditions.

    The impact of UNRWA’s ban will extend beyond Gaza. Critical services, including refugee camp management, health services, education, and social programmes across the West Bank are also at risk of destabilisation under this legislation. This legislation sets a grave precedent for other conflict situations where governments may wish to eliminate an inconvenient United Nations presence.

    For months, international leaders and organisations, including MSF, have raised warnings about the disastrous potential of these newly adopted bills. Yet Israel has chosen to press forward with measures that will undermine vital assistance, endangering Palestinian lives and intensifying the collective punishment they face.

    This vote adds to the endless physical and bureaucratic impediments imposed by Israel to limit the amount of aid reaching Gaza, and blatantly contradicts Israel’s claims that it is facilitating humanitarian assistance into the Strip.

    MSF Australia was established in 1995 and is one of 24 international MSF sections committed to delivering medical humanitarian assistance to people in crisis. In 2022, more than 120 project staff from Australia and New Zealand worked with MSF on assignment overseas. MSF delivers medical care based on need alone and operates independently of government, religion or economic influence and irrespective of race, religion or gender. For more information visit msf.org.au  

    MIL OSI – Submitted News –

  • MIL-OSI Global: Five reasons weight-loss jabs alone won’t help get people back to work

    Source: The Conversation – UK – By Lucie Nield, Senior Lecturer in Nutrition and Dietetics, University of Sheffield

    Weight-loss injectables don’t address the many core reasons for why weight gain and unemployment occur in the first place. oleschwander/ Shutterstock

    Prime Minister Keir Starmer and health secretary Wes Streeting have recently discussed plans to trial weight-loss injections for around 250,000 people with obesity who are unemployed in a bid to get them back into work, ease pressure on the NHS and boost the economy.

    Obesity is estimated to cost UK society around £35 billion annually. This is due to lower productivity and higher NHS treatment costs.

    Around 26% of the English adult population (approximately 15 million) are considered obese. However, it’s not known what proportion of unemployed people are obese.

    While weight-loss injections have proven to be very effective in helping people who are obese to lose weight and lower their risk of certain chronic diseases, there are many reasons why these drugs alone won’t help tackle obesity and unemployment rates in the UK.

    1. Lack of capacity

    The majority of UK people who are obese are likely to meet the National Institute for Health and Care Excellence’s eligibility criteria for weight-loss injections.

    But prescribing these drugs is just one part of the equation. Eligible patients will require support from specialist services who provide guidance in making the appropriate lifestyle changes (such as to their diet) to successfully lose weight while on these drugs. This is crucial, as all of the weight-loss injection trials to date have involved a behaviour change component. This may potentially be key to the successful weight losses observed in these studies.

    However, current demand for weight-loss services is already outstripping capacity. Nearly half of eligible patients in England are unable to get an appointment with a specialist team. Weight-loss injections can only be prescribed through such services currently. If the government is to roll out the proposed programme, they will need to rethink the way weight-loss services are delivered so all eligible patients can access support.

    2. Won’t work for everyone

    Weight-loss jabs don’t necessarily work for everyone. One study found that 9-15% of participants who took the drug tirzepatide (Mounjaro) did not lose clinically significant amounts of weight.

    Weight-loss jabs may also cause intolerable side-effects for some. Trials have shown between 4-8% of participants couldn’t tolerate the side-effects, causing them to drop out of the study. Constipation, diarrhoea and nausea are some of the most commonly reported.

    People with certain health conditions may be unable to use weight-loss injections – such as those with inflammatory bowel disease and pancreatitis. In such cases, weight-loss jabs may worsen symptoms or interact with the prescription drugs used to manage these conditions, increasing risk of harm.

    There are many reasons why weight loss jabs may not work for a person.
    Mohammed_Al_Ali/ Shutterstock

    Additionally, some people may not want to take an injection – whether that’s simply due to personal preference or even fear of needles.

    3. Obesity is a complex issue

    There are many complex factors that contribute to weight gain – such as opportunities for physical activity, access to healthy foods and levels of deprivation in a community. Prescribing weight-loss jabs to help people lose weight may not be effective long-term if the rest of these factors are not also addressed.

    A more effective way of seeing significant, sustainable reductions in obesity levels across a population is by using a “whole systems approach”. This would address to the multiple environmental, social and economic factors that contribute to obesity.

    Where whole systems approaches have been embedded in healthcare design and delivery, they have led to improvements in services and patient outcomes – including obesity-related metrics (such as patients making healthier food choices and being more active).

    However, one limitation to whole systems approaches is challenges in measuring impact. This can reduce political will to implement these approaches.

    4. Obesity stigma

    Obesity stigma in the workplace is a huge barrier to satisfactory employment and leads to poor wellbeing and burnout.

    Obesity stigma in the workplace perpetuates harmful weight-based stereotypes that overweight and obese people are lazy, unsuccessful, unintelligent and lack willpower. As a result, people with obesity are more likely to be in insecure and lower-paid jobs than those who may be considered of a healthy weight.

    It’s also well-evidenced that regular exposure to stigmatising, isolating and degrading prejudices has long-term consequences on physical and mental health – and may lead to problems such as binge eating and depression.This can lead to a loss of productivity, absenteeism and loneliness.

    Prescribing weight-loss jabs to help a person lose weight doesn’t address the core reasons for why they may have been absent from work or unemployed in the first place. Nor does it help to address the mental health struggles they may still harbour as a result of discrimination they might have experienced.

    5. Barriers to employment

    Weight loss alone does not begin to address the complex physical and mental health reasons for why a person might be unemployed. A person may also be unemployed due to factors such as caring responsibilities or disability.

    Current prescribing restrictions also limit some injections to a maximum of 24 months (although further trials are ongoing). This means that even if a person has successfully lost weight, they may regain that weight again when they stop using the drug. This could mean any health problems they experienced prior to losing weight (and which may have prevented them from being in employment) could reemerge.

    There are better ways of getting people back into work than prescribing weight-loss jabs. Flexible working approaches, for instance, may make it easier for someone who is unemployed due to caring responsibilities or health problems to transition back into employment. Supportive policies and workplace wellbeing programmes may be a more cost-effective way of helping people to overcome barriers, improve their health and transition back into work.

    Lucie Nield has received funding from The National Institute for Health Research (NIHR) for evaluation of children’s weight management services.

    Lucie Nield sits on the Board of Trustees for Darnall Wellbeing (a local community service organisation).

    – ref. Five reasons weight-loss jabs alone won’t help get people back to work – https://theconversation.com/five-reasons-weight-loss-jabs-alone-wont-help-get-people-back-to-work-241835

    MIL OSI – Global Reports –

  • MIL-OSI Russia: Head of the Kirov Military Medical Academy Evgeny Kryukov became an Honorary Doctor of the Polytechnic University

    Translation. Region: Russian Federation –

    Source: Peter the Great St Petersburg Polytechnic University – Peter the Great St Petersburg Polytechnic University –

    At the meeting of the Academic Council of the Polytechnic University on October 30, a ceremony was held to present the diploma and mantle of the Honorary Doctor of SPbPU to the head of the S. M. Kirov Military Medical Academy (VMedA), Lieutenant General of the Medical Service, Academician of the Russian Academy of Sciences Evgeny Kryukov.

    The decision to award the honorary title to Evgeny Kryukov was made unanimously by the members of the Academic Councilmeeting on May 24 this year.

    Evgeny Vladimirovich graduated with a gold medal from the military medical faculty of the Gorky Medical Institute, served in the Black Sea Fleet as a doctor and head of the medical service of a submarine. He was a senior resident and head of the therapeutic department, chief therapist, and since 2009 – head of the Naval Hospital named after Academician N. I. Pirogov. From 2014 to 2020, he headed the Main Military Clinical Hospital named after Academician N. N. Burdenko. In 2020, he was appointed to the post of head of the Military Medical Academy named after S. M. Kirov.

    Evgeny Vladimirovich is a legendary man who has visited all the hot spots, a doctor with a capital letter. In our difficult times, he heads the Military Medical Academy named after Sergei Mironovich Kirov, famous for the names of outstanding scientists and healers. It is the highest honor for us to accept you, Evgeny Vladimirovich, into our ranks as an Honorary Doctor of the Polytechnic University, – the rector of SPbPU, chairman of the St. Petersburg branch of the Russian Academy of Sciences Andrei Rudskoy opened the ceremony.

    The new Honorary Doctor of the University was presented by the University Scientific Secretary Dmitry Karpov: Today, the large family of Polytechnicians welcomes a man for whom caring for the lives of others has become his life’s work. Often, saving lives. Evgeny Vladimirovich is a military doctor: from the Crimean Medical Institute and the Military Medical Faculty of the Gorky Medical Institute, which he graduated with honors, to the title of Honored Doctor of Russia and veteran of military service. Evgeny Vladimirovich is a scientist: since 1994 – Candidate of Medical Sciences, since 2004 – Doctor of Sciences, since 2016 – Corresponding Member of the Russian Academy of Sciences in the Department of Medical Sciences, since 2022 – Academician of the Russian Academy of Sciences in the specialty of “military field therapy”. The author of more than six hundred scientific papers, prepared eleven candidates and doctors of science.

    Dmitry Karpov noted that Evgeny Kryukov contributed to the formation of a system for providing troops in armed conflicts, the creation of principles for interaction between military and civilian healthcare, and the adjustment of the scientific process to the needs of the army and navy.

    Dmitry Anatolyevich also said that Yevgeny Vladimirovich made a significant contribution to the fight against the COVID-19 pandemic and participated in the trials of the Sputnik V vaccine. As the head of the Main Military Clinical Hospital at the time, Yevgeny Kryukov put on a protective suit and carried out procedures in the red zone himself to understand the operating conditions of medical personnel. For his dedicated work during the pandemic, he received the specially established Pirogov Order. Yevgeny Vladimirovich’s awards also include the Certificate of Honor of the President of the Russian Federation (2021), the Order of Honor (2022) and “For Military Merit” (2024).

    Evgeny Kryukov significantly strengthened the ties of the Military Medical Academy with the Russian Academy of Sciences and relevant international organizations. In conclusion of the presentation, Dmitry Karpov expressed confidence that such a connection will also be strengthened with the St. Petersburg Polytechnic University.

    After all the welcoming words, the rector of the Polytechnic gave the command: Bring in the Honorary Doctorate Diploma, the mantle and the medal!

    According to tradition, the doctoral gown and cap were brought into the hall of the Academic Council by students dressed in the uniform of polytechnics of the early 20th century. The ceremony was accompanied by the Gaudeamus anthem performed by the Polyhymnia choir. Yevgeny Vladimirovich was also presented with a book about the Honorary Doctors of the Polytechnic — his page is already in it.

    In his response, Evgeny Kryukov thanked the members of the Academic Council for the honor of being elected as an Honorary Doctor of the country’s leading engineering university.

    Our cooperation in medicine dates back about sixty years, when the Department of Biophysics was created at the Polytechnic University. In 1997, the outstanding professor of the Military Medical Academy Vladimir Olegovich Samoilov headed the faculty of medical physics at your university, – said Evgeny Vladimirovich. – Over this time, more than a hundred people have been awarded the high honor of becoming Honorary Doctors of the Polytechnic University, mainly representatives of engineering and exact sciences. Today’s event is especially valuable for me, because for the first time a doctor has been elected Honorary Doctor of the Polytechnic University. First of all, this is, of course, the merit of scientific schools, professors of the Military Medical Academy, the merit of all military medicine. Your decision demonstrates the unity of science, the army and society. Probably, it was this unity that allowed our country to win victories over enemies in all historical periods, preserve its cultural identity and gave a powerful incentive to the scientific and technical development of the country. It is symbolic that this event is taking place on the eve of the great holiday of National Unity Day.

    At the end of the ceremony, the rector of the Polytechnic invited Evgeny Kryukov, as an Honorary Doctor, to support the tradition and give a lecture to the students.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    MIL OSI Russia News –

  • MIL-OSI United Kingdom: UKHSA detects first case of Clade Ib mpox

    Source: United Kingdom – Government Statements

    The UK Health Security Agency (UKHSA) has detected a single confirmed human case of Clade Ib mpox.

    The UK Health Security Agency (UKHSA) has detected a single confirmed human case of Clade Ib mpox. The risk to the UK population remains low.

    This is the first detection of this Clade of mpox in the UK. It is different from mpox Clade II that has been circulating at low levels in the UK since 2022, primarily among gay, bisexual and other men-who-have-sex-with-men (GBMSM).

    UKHSA, the NHS and partner organisations have well tested capabilities to detect, contain and treat novel infectious diseases, and while this is the first confirmed case of mpox Clade Ib in the UK, there has been extensive planning underway to ensure healthcare professionals are equipped and prepared to respond to any confirmed cases.

    The case was detected in London and the individual has been transferred to the Royal Free Hospital High Consequence Infectious Diseases unit. They had recently travelled to countries in Africa that are seeing community cases of Clade Ib mpox. The UKHSA and NHS will not be disclosing any further details about the individual.

    Close contacts of the case are being followed up by UKHSA and partner organisations. Any contacts will be offered testing and vaccination as needed and advised on any necessary further care if they have symptoms or test positive.

    UKHSA is working closely with the NHS and academic partners to determine the characteristics of the pathogen and further assess the risk to human health. While the existing evidence suggests mpox Clade Ib causes more severe disease than Clade II, we will continue to monitor and learn more about the severity, transmission and control measures. We will initially manage Clade Ib as a high consequence infectious disease (HCID) whilst we are learning more about the virus.

    Professor Susan Hopkins, Chief Medical Adviser at UKHSA, said:

    It is thanks to our surveillance that we have been able to detect this virus. This is the first time we have detected this Clade of mpox in the UK, though other cases have been confirmed abroad.

    The risk to the UK population remains low, and we are working rapidly to trace close contacts and reduce the risk of any potential spread. In accordance with established protocols, investigations are underway to learn how the individual acquired the infection and to assess whether there are any further associated cases.

    Health and Social Care Secretary Wes Streeting, said:

    I am extremely grateful to the healthcare professionals who are carrying out incredible work to support and care for the patient affected.

    The overall risk to the UK population currently remains low and the government is working alongside UKHSA and the NHS to protect the public and prevent transmission.

    This includes securing vaccines and equipping healthcare professionals with the guidance and tools they need to respond to cases safely.

    We are also working with our international partners to support affected countries to prevent further outbreaks.

    Steve Russell, NHS national director for vaccination and screening, said:

    The NHS is fully prepared to respond to the first confirmed case of this clade of mpox.

    Since mpox first became present in England, local services have pulled out all the stops to vaccinate those eligible, with tens of thousands in priority groups having already come forward to get protected, and while the risk of catching mpox in the UK remains low, if required the NHS has plans in place to expand the roll out of vaccines quickly in line with supply.

    Clade Ib mpox has been widely circulating in the Democratic Republic of Congo (DRC) in recent months and there have been cases reported in Burundi, Rwanda, Uganda, Kenya, Sweden, India and Germany.

    Clade Ib mpox was detected by UKHSA using polymerase chain reaction (PCR) testing.

    Common symptoms of mpox include a skin rash or pus-filled lesions which can last 2 to 4 weeks. It can also cause fever, headaches, muscle aches, back pain, low energy and swollen lymph nodes.

    The infection can be passed on through close person-to-person contact with someone who has the infection or with infected animals and through contact with contaminated materials. Anyone with symptoms should continue to avoid contact with other people while symptoms persist.

    The UK has an existing stock of mpox vaccines and last month announced further vaccines are being procured to support a routine immunisation programme to provide additional resilience in the UK. This is in line with more recent independent JCVI advice.

    Working alongside international partners, UKHSA has been monitoring Clade Ib mpox closely since the outbreak in DRC first emerged, publishing regular risk assessment updates.

    The wider risk to the UK population remains low.

    UKHSA has published its first technical briefing on clade I mpox which provides further information on the current situation and UK preparedness and response.

    Updates to this page

    Published 30 October 2024

    MIL OSI United Kingdom –

  • MIL-OSI Europe: Answer to a written question – Consequences of the judgment of the Court of Justice of the EU – P-001898/2024(ASW)

    Source: European Parliament

    On 27 September 2024, the Commission has lodged appeals against the two judgments of the General Court of 17 July 2024, seeking to partially annul the confirmatory decisions in cases T-689/21 Auken and others v Commission[1] and T-761/21 Courtois and others v Commission[2], concerning public access to the unredacted versions of the contracts for the purchase of COVID-19 vaccines.

    The latter case concerned, in addition, access to the declarations of absence of conflict of interests signed by the representatives in the EU-Member States Joint Negotiation Team.

    • [1] https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A62021TJ0689
    • [2]  https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A62021TA0761
    Last updated: 29 October 2024

    MIL OSI Europe News –

  • MIL-OSI Europe: Answer to a written question – Authorisation of Mpox vaccines and transparency – P-001831/2024(ASW)

    Source: European Parliament

    The Commission authorises medicines based on a recommendation by the European Medicines Agency (EMA).

    The vaccine Imvanex[1] is authorised in the EU to protect against smallpox, mpox and diseases caused by vaccinia virus in individuals aged 12 and older.

    The product information[2] includes advice on the use of Imvanex in vulnerable populations, such as immunocompromised, pregnant women or children.

    The recommendation to extend the use of Imvanex to adolescents is based on the interim results of a study[3] showing its ability to generate an immune response in adolescents similar to that in adults.

    No additional risk was identified for the use of Imvanex in adolescents compared to adults. EMA requested the marketing authorisation holder to submit the study final results by 30 May 2025 to further characterise the safety information for adolescents[4].

    As for all medicines, data on the use of Imvanex are continuously monitored. Side effects reported with Imvanex are evaluated, and any necessary action taken to protect patients.

    On 13 September 2024, Imvanex was prequalified by the World Health Organisation (WHO)[5], with EMA as regulatory agency of record, i.e. EMA’s assessment was the basis for WHO prequalification to facilitate timely and increased access to this vaccine in communities with urgent need.

    WHO also cooperated in EMA’s assessment of the extension of indication to adolescents, a population particularly vulnerable to mpox.

    The Commission will continue to strive for the greatest transparency possible by complying with Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents[6] when applicable.

    • [1] Union Register of medicinal products https://ec.europa.eu/health/documents/community-register/html/h855.htm
    • [2] IMVANEX II-108 https://ec.europa.eu/health/documents/community-register/2024/20240919164097/anx_164097_en.pdf
    • [3] A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox https://www.clinicaltrials.gov/study/NCT05740982
    • [4] EMA recommends extending indication of mpox vaccine to adolescents https://www.ema.europa.eu/en/news/ema-recommends-extending-indication-mpox-vaccine-adolescents
    • [5] https://www.who.int/news/item/13-09-2024-who-prequalifies-the-first-vaccine-against-mpox
    • [6] https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A32001R1049

    MIL OSI Europe News –

  • MIL-OSI Europe: MOTION FOR A RESOLUTION on the creation of a European fund, financed by the extraordinary profits from ‘COVID-19 vaccines’, to compensate victims and to finance research into the treatment of long COVID and its persistent side-effects – B10-0067/2024

    Source: European Parliament

    B10‑0067/2024

    Motion for a European Parliament resolution on the creation of a European fund, financed by the extraordinary profits from ‘COVID-19 vaccines’, to compensate victims and to finance research into the treatment of long COVID and its persistent side-effects

    The European Parliament,

    – having regard to Rule 149 of its Rules of Procedure,

    A. whereas extraordinary profits were made by Pfizer (35 billion), BioNTech (20 billion) and Moderna (20 billion) in 2021/2022[1];

    B. whereas 1.7 million adverse – and sometimes very serious – reactions have been reported to the European Medicines Agency[2];

    C. whereas, according to the European Medicines Agency, 12 000 people have died in the European Union from COVID-19 vaccines:

    D. whereas 17 million people have reportedly experienced persistent symptoms after contracting COVID-19 or after being vaccinated against it[3];

     

    1. Calls on the European Commission to create a fund, financed by the extraordinary profits from ‘COVID-19 vaccines’, to compensate victims and to finance research into the treatment of long COVID and its persistent side-effects;

     

    2. Instructs its President to forward this resolution to the Commission and the Member States.

     

    MIL OSI Europe News –

  • MIL-OSI Asia-Pac: Prime Minister Shri Narendra Modi Inaugurates, Lays Foundation Stone of several projects and Launches various Health Programmes across 4 Ministries on Dhanvantari Jayanti, significantly enhancing health infrastructure across the country

    Source: Government of India

    Prime Minister Shri Narendra Modi Inaugurates, Lays Foundation Stone of several projects and Launches various Health Programmes across 4 Ministries on Dhanvantari Jayanti, significantly enhancing health infrastructure across the country

    Various initiatives amounting to more than Rs. 12,855 Cr, include projects worth more than Rs. 5502 Cr under the Ministry of Health & Family Welfare; Rs. 5187 Cr under Dept. of Pharmaceuticals, Ministry of Chemicals & Fertilizers; Rs. 1641 under ESIC, Ministry of Labour and Employment and Rs. 525.14 Cr under the Ministry of AYUSH

    Prime Minister Unveils Comprehensive Five-Pillar Health Policy Focused on Preventive Care and Accessibility

    Prime Minister Launches Expansion of Health Coverage under AB-PMJAY for citizens of and above 70 years, at a cost of Rs. 3437 Crore

    Every senior citizen in the country aged 70 and above will receive free hospital treatment through the Ayushman Vaya Vandana Card: Prime Minister

    “Health is regarded as the greatest wealth, a concept that is gaining global recognition through Yoga”

    Prime Minister Reiterates Commitment to add 75,000 New MBBS and MD Seats to Meet Rising Demand

    Prime Minister Inaugurates Phase-II of India’s First All India Institute of Ayurveda in New Delhi, Central Drugs Testing Laboratory in Bhubaneswar, Odisha; 3 Government Medical Colleges in Madhya Pradesh; 5 projects under PLI Scheme for medical devices and drugs; 4 Centers of Excellence of AYUSH; and many projects at various AIIMS; Inaugurates ESIC hospital at Indore

    Prime Minister lays Foundation Stone for 5 Nursing Colleges in Madhya Pradesh; 21 Critical Care Blocks under PM-ABHIM in 5 States; 2 Yoga & Naturopathy Institutes in Odisha & Chhattisgarh; upgradation projects at AIIMS New Delhi and Bilaspur; 06 ESI hospitals in 5 States and 4 Centres of Excellence at NIPERs in 4 States

    Prime Minister Launches U-WIN portal for digitalization of Immunization services for pregnant women and children, enhancing access to health services and providing citizens with secure digital identities

    Prime Minister Launches Nationwide Campaign “Desh Ka Prakriti Parikshan Abhiyan” to promote Health Awareness among Citizens

    Posted On: 29 OCT 2024 5:30PM by PIB Delhi

    In a landmark development aimed at strengthening India’s healthcare infrastructure and providing quality healthcare services across the country, Prime Minister Shri Narendra Modi inaugurated and laid the foundation stone of several health infrastructure projects, and launched various health programmes across the Ministry of Health & Family Welfare, Ministry of Ayush, Dept. of Pharmaceuticals, Ministry of Chemicals & Fertilizers, and Employees’ State Insurance Corporation (ESIC) under Ministry of Labour & Employment at an event at All India Institute of Ayurveda (AIIA), here today. The total outlay of these projects amounts to more than 12,855 cr.

    Union Minister of Health and Family Welfare, Shri Jagat Prakash Nadda; Union Minister of Labour and Employment, Dr. Mansukh Mandaviya; Union Minister of State (Independent Charge) for AYUSH and Union MoS for Health and Family Welfare, Shri Prataprao Jadhav; Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel; Union Minister of State for Labour and Employment, Smt. Shobha Karandlaje and Shri Ramvir Singh Bidhuri, South Delhi MP (Lok Sabha) were also present on the occasion.

    Today marks 9th ‘Ayurveda Day’, which is celebrated in India and many other countries on the occasion of Dhanvantari Jayanti. It is a day to celebrate the birth of Lord Dhanvantari, God of Ayurveda. Quoting sages and saints, Prime Minister emphasized that “health is regarded as the greatest wealth, a concept that is gaining global recognition through Yoga”. He expressed joy that Ayurveda Diwas is now celebrated in over 150 countries, highlighting the increasing global interest in Ayurveda and India’s ancient contributions to the world.

    Prime Minister said that in the past decade, the country had witnessed beginning of a new chapter in the health sector with amalgamation of knowledge of Ayurveda with Modern medicine, adding that the All India Institute of Ayurveda had been a focal point of this chapter. He noted that it would be possible to see ancient techniques like Panchakarma infused with modern technology in this institute along with advanced research studies in the fields of Ayurveda and medical science.

    Prime Minister underscored that “a nation’s progress is closely linked to the health of its citizens”, outlining the government’s commitment to healthcare through five key pillars: preventive healthcare, early disease detection, affordable treatment and medications, increased doctor availability in smaller towns, and technological advancements in health services. He stated that India’s approach to health is holistic and highlighted recent projects worth over ₹13,000 crores, including four Centers of Excellence under the Ayush Health scheme, drone service expansions, new infrastructure at various AIIMS, and the establishment of medical colleges. He expressed satisfaction with hospitals being built for laborers, which will serve as dedicated treatment centres. The inauguration of pharmaceutical units aimed at manufacturing advanced medicines and quality stents and implants was also mentioned.

    Reflecting on the struggles many families face due to illness, especially in poorer households, Shri Modi noted that people previously had to sell their possessions for medical care. He said that “to alleviate this burden, the government introduced the Ayushman Bharat Yojana, which covers up to ₹5 lakh in hospitalization costs for the poor”. He highlighted that around 4 crore individuals have benefited from this scheme, ensuring that they receive treatment without financial strain. He expressed pride in expanding the Ayushman Yojana to include free treatment for all citizens over 70 years old, through the Ayushman Vaya Vandana Card, which is universally accessible regardless of income.

    Reiterating the focus on reducing healthcare costs for both the poor and middle class, Prime Minister noted launch of over 14,000 Jan Aushadhi Kendras, providing medicines at an 80% discount and saving citizens ₹30,000 crores. He highlighted reductions in the prices of medical devices like stents and knee implants, preventing a loss of over ₹80,000 crores for the public. He also mentioned the free dialysis scheme and the Mission Indradhanush yojana, aimed at preventing severe diseases and protecting mothers and newborns.

    Prime Minister emphasized the importance of timely diagnosis to mitigate health risks and mentioned the establishment of nearly two lakh Ayushman Arogya Mandirs, facilitating early detection of diseases like cancer and diabetes. He noted that these centres help millions access timely treatment, ultimately reducing costs. Additionally, the government is leveraging technology through the e-Sanjeevani scheme, which has enabled over 30 crore online consultations, significantly lowering healthcare expenses. He announced the launch of the U-win platform, enhancing access to health services in India by providing citizens with secure digital identities. The Made-in-India digital platform will benefit 2.9 crore pregnant women and 2.6 crore infants annually by fully digitalising the complete vaccination process. It will ensure the timely administration of life-saving vaccines to women and children (from birth to 16 years) against 12 vaccine-preventable diseases under the Ministry of Health and Family Welfare’s flagship Universal Immunization Programme (UIP).

     

    Prime Minister concluded his address by reflecting on the substantial progress in India’s healthcare over the last decade compared to the previous decades, noting the record establishment of new AIIMS and medical colleges. He cited recent inaugurations in states like Karnataka, Uttar Pradesh, Madhya Pradesh, and Andhra Pradesh, as well as new medical colleges being developed. He assured that the increasing number of hospitals correlates with a rise in medical education opportunities, promising that no child’s dream of becoming a doctor would be hindered by lack of options in India, with nearly 1 lakh new MBBS and MD seats added in the past decade and a commitment to announce an additional 75,000 seats in the next five years.

    Speaking on the occasion, Shri JP Nadda said, “the health policy presented today by Prime Minister Shri Narendra Modi has two special features. The first characteristic is that it is holistic; In this, all aspects of preventive, promotional, curative, rehabilitative and palliative have been taken care of. The second feature is that the effort made in bringing all the genres together under one roof is very significant and will always be remembered.”

    He also reiterated that the Union Government will provide a health cover of ₹ 5 lakh to any elderly person above 70 years of age, any woman, any caste, any community, and any area, and will make arrangements for their treatment free of cost, adding that this facility will be available throughout their life.

    Shri Prataprao Jadhav noted that since 2014, Ayurveda’s involvement in global health has gained a new dimension and credited the Prime Minister for his exemplary contribution towards this. He informed that ‘Support Ayurveda’ initiative has been launched with the aim of spreading global awareness of Ayurveda.

    Details of Projects:

    Various projects and facilities falling under the Union Health Ministry amounting to more than Rs. 1133 Cr were inaugurated by the Prime Minister today. These include three Medical Colleges at Mandsaur, Neemuch and Seoni in Madhya Pradesh; facility and service extensions at AIIMS in Bilaspur (Himachal Pradesh); Kalyani (West Bengal), Patna (Bihar), Gorakhpur (Uttar Pradesh), Bhopal (Madhya Pradesh), Guwahati (Assam), and New Delhi where a Jan Aushadhi Kendra was inaugurated; a Super Speciality Block in Government Medical Colleges at Bilaspur (Chhattisgarh); a Central Drugs Testing Laboratory (CDTL) in Gothapatna, Bhubaneswar, Odisha and a Critical Care Block in Bargarh, Odisha.

    In addition, Prime Minister laid the foundation stone for various health infrastructure projects amounting to more than Rs. 925 cr. These include five Nursing Colleges in Madhya Pradesh (Shivpuri, Ratlam, Khandwa, Rajgarh, and Mandsaur); 21 Critical Care Blocks in states of Himachal Pradesh, Karnataka, Manipur & Tamil Nadu, and Rajasthan under PM-ABHIM; and several facilities and service extensions at AIIMS, New Delhi and AIIMS Bilaspur, Himachal Pradesh.

    With the aim of enhancing access to health services in India by providing citizens with fully digitalized immunization services for pregnant women and children and secure digital identities, Prime Minister launched the U-WIN portal today. This Made-in-India digital platform will benefit 2.9 crore pregnant women and 2.6 crore infants annually by fully digitalizing the complete vaccination process. It will ensure the timely administration of life-saving vaccines to pregnant women and children (from birth to 16 years) against 12 vaccine-preventable diseases. As a major addition to the flagship scheme AB PM-JAY, Prime Minister launched expansion of health coverage to all senior citizens aged 70 yrs and above, regardless of their income, at a cost of Rs. 3437 crores.  

    To extend the reach of healthcare services to hard-to-reach areas, Prime Minister launched drone services at 11 Tertiary Care Institutions. These are AIIMS Rishikesh (Uttarakhand), AIIMS Bibinagar (Telangana), AIIMS Guwahati (Assam), AIIMS Bhopal (Madhya Pradesh), AIIMS Jodhpur (Rajasthan), AIIMS Patna (Bihar), AIIMS Bilaspur (Himachal Pradesh), AIIMS Raebareli (Uttar Pradesh, AIIMS Raipur (Chhattisgarh), RIMS Imphal (Manipur) and AIIMS Mangalagiri (Andhra Pradesh). A Helicopter Emergency Medical Services from AIIMS Rishikesh was also launched which will help to deliver speedy medical care by stabilizing and treating trauma victims during flight and onsite. It will cover Uttarakhand and nearby areas within 100 nautical miles. In addition, Prime Minister launched a portal for Allied Healthcare professionals and institutes. This is a centralized database of existing Allied and Healthcare Professionals and institutes. Moreover, State specific Action Plan on Climate Change and Human Health (SAPCCHH) for each State and UT was also launched, which lays out adaptation strategies towards developing climate resilient healthcare services in these States/UTs.

    Under the Dept. of Pharmaceuticals, five projects under Production Linked Incentive (PLI) scheme for Medical Devices and bulk drugs was inaugurated at Vapi (Gujarat); Sultanpur, (Hyderabad); Bengaluru, (Karnataka); Kakinada (Andhra Pradesh) and Nalagarh (Himachal Pradesh). These units will manufacture high-end medical devices, such as body implants and critical care equipment, along with important bulk drugs like Penicillin-G and Clavulanic Acid. These initiatives support India’s goal of reducing import dependence and enhancing local manufacturing capabilities in medical devices and bulk drugs. Prime Minister also laid the foundation stone of four Centres of Excellence at NIPER –Ahmedabad (Gujarat) for Medical Devices; NIPER Hyderabad (Telangana) for Bulk Drugs; NIPER, Guwahati (Assam) for Phytopharmaceuticals; and NIPER – Mohali (Punjab) for Anti-Bacterial Anti-Viral Drug Discovery and Development. The total outlay for the Dept. of Pharmaceutical projects is about Rs. 5187 crores.

    In addition, under Ministry of Labour and Employment, Prime Minister inaugurated a 300 bedded ESIC Hospital which is upgradable to 500 beds at Indore (Madhya Pradesh), and laid the foundation stone for various ESI Hospitals across Faridabad (Haryana), Bommasandra (Karnataka) & Narasapur, Indore (Madhya Pradesh), Meerut (Uttar Pradesh), and Atchutapuram (Andhra Pradesh) at a cumulative cost of Rs 1641 crores. These projects will bring healthcare benefits to 55 lakh ESI beneficiaries.

    Under the Ministry of AYUSH, Prime Minister inaugurated Phase II of the All India Institute of Ayurveda (AIIA), originally dedicated in 2017, which includes a 150-bedded Panchakarma hospital, an Ayurvedic pharmacy, a sports medicine unit, and extensive accommodation facilities, all at a cost of over ₹289 crores. To enhance India’s health and wellness solutions, he also laid the foundation for two Central Research Institutes in Yoga and Naturopathy in Odisha and Chhattisgarh, and launched four Centers of Excellence focused on diabetes research, sustainable Ayurvedic solutions, Ayurvedic botanical research, and systems medicine for rheumatoid arthritis. Additionally, a nationwide health awareness campaign, “Desh Ka Prakriti Parikshan Abhiyan,” was launched with 470,000 volunteers, aiming to revolutionize public health awareness and attempt multiple Guinness World Records.

    ***

    MV

    HFW/PM Launch of Health Initiatives/29th October 2024/1

    (Release ID: 2069266) Visitor Counter : 24

    MIL OSI Asia Pacific News –

  • MIL-OSI USA: FDA Roundup: October 29, 2024

    Source: US Food and Drug Administration

    For Immediate Release:

    Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: 

    • Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for modifying the final rule. However, the FDA is working on an updated safety assessment of the remaining authorized uses, including considering information we have received through our request for information, and phthalates are included on the list of select chemicals under FDA review.
    • On Monday, the FDA announced a hybrid meeting, In Vitro Diagnostics (IVD) Roundtable, that will be held on Nov. 12, 2024, at 10 a.m. ET. The meeting will provide a forum to facilitate communication between the FDA and IVD industry. Participants can attend in-person or virtually. Space is limited for in-person attendance. There is no fee to attend, and registration is required. To attend in person, register by Oct. 30, 2024. To attend virtually, register by Nov. 12, 2024.
    • On Monday, the FDA shared information about medical device cybersecurity. Like other electronics, medical devices can be vulnerable to security breaches, potentially impacting the safety and effectiveness of the device. Informed by patient voices and collaborations with industry, government agencies, and health care delivery organizations, the FDA will continue to drive and refine medical device cybersecurity policy. Before Cybersecurity Awareness Month ends, check out these recent publications that may be generally informative to help keep medical devices operating safely.
    • On Friday, the FDA issued a safety communication to alert consumers, health care providers, and health care facilities not to use BioZorb Markers and BioZorb LP Markers by Hologic Inc. On Oct. 25, 2024, Hologic announced a voluntary recall for removal of all lots of unused BioZorb Markers. The recall is due to reports of serious adverse events occurring in patients who had the devices implanted in breast tissue. 
    • On Friday, the FDA granted marketing authorization of Distalmotion, SA’s Dexter L6 System, an electromechanical surgical system intended to repair inguinal hernias through minimally invasive procedures using high-precision surgical endoscopic instruments. The Dexter L6 System includes a console surgeons use to control movements of the different parts of the system, separate carts that can be positioned next to the operating room table, and arms that get attached to the carts and that can hold and manipulate different endoscopic instruments based on motions captured on the surgeon-controlled console. Although the Dexter L6 Surgical System operates using similar principles as other robotically assisted surgery device systems, it allows for the surgeon and the user interface to be in the sterile field, unlike other authorized devices. The Dexter L6 System is intended for use by trained laparoscopic surgeons on patients 22 years of age or older. This authorization reinforces the FDA’s commitment to providing physicians and patients with minimally invasive surgery options to treat relatively common conditions, such as inguinal hernias.
    • On Friday, three individuals in London were sentenced for their role in the international importation and distribution of unapproved drugs. The operation seized over £1M ($1.3M) and 1 million illicit pills. This result is the culmination of numerous law enforcement agencies, including the FDA Office of Criminal Investigations (FDA-OCI), working together from across the world for more than three years. The investigation began in October 2020 when U.S. Customs and Border Protection seized numerous shipments sent from the U.K. found to contain illicit drugs. Information sharing between FDA-OCI and the City of London Police led to the successful execution of warrants in the U.S., where illicit unapproved drugs were found.

    Related Information

    Related Information

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.

    Inquiries

    Consumer:
    888-INFO-FDA

    MIL OSI USA News –

  • MIL-OSI USA: USAID Announces More Than $57 Million to Drive Agricultural Innovation

    Source: USAID

    The United States, through USAID, committed $57.4 million, working with Congress, to accelerate food security initiatives and advance novel climate-smart agricultural solutions to reduce global hunger, poverty, and undernutrition. Announced at the 2024 World Food Prize Borlaug Dialogue in Iowa, more than $38 million will support Feed the Future – the U.S. government’s global hunger initiative – Innovation Labs.

    The Feed the Future Innovation Lab network, including two newly funded labs, will advance technology development and draw on the expertise of top U.S. universities and host country research institutions to tackle some of the world’s greatest challenges in agriculture and food security. The Climate Resilient Sustainable Intensification lab, led by Kansas State University, will conduct research to develop and adapt technologies that increase agricultural productivity on less land with fewer environmental tradeoffs. At Washington State University, the Veterinary Vaccine Delivery lab will accelerate the development and deployment of cold-chain-independent vaccines for livestock.

    New investments in existing labs include World Coffee Research joining Cornell University to develop improved coffee varieties and the University of Florida partnering with the University of California, Davis to address poultry disease through advances in chicken breeding. Cornell, Purdue, and Michigan State Universities have been awarded extensions to continue work on climate resilient crops, food safety policies and regulations, and local food security policy, respectively.

    The remainder of the funding includes an award to accelerate the development and deployment of disease-resistant wheat varieties through a partnership with the U.S. Department of Agriculture and CIMMYT; a contribution to the Global Crop Diversity Trust to increase the availability of adapted crops and seeds to meet the challenges of new pests and diseases, higher temperatures, less water, and soil degradation; and funding to non-profit Akademiya2063 to support African leadership on agriculture policy reform.

    Feed the Future has continued to deliver strong results, as demonstrated in this year’s newly launched Feed the Future Interagency Report. In the initiative’s first decade both hunger and poverty fell by 20 to 25 percent in areas of focus. In 2023 alone, Feed the Future worked with 6.2 million producers to apply improved agricultural practices on 4.5 million hectares of cropland and cultivated pasture. In addition, small and medium businesses and farmers accessed $1.4 billion in agriculture-related financing and leveraged $677 million in private-sector investment – double the level in fiscal year 2020 – resulting in record sales of more than $4.6 billion. 

    Building on this success, Feed the Future will continue to work with partner countries, donors, and both the public and private sector in the United States and abroad to accelerate transformational change.

    MIL OSI USA News –

  • MIL-OSI Video: Middle East: UN official urges end to military activities to prevent an all-out regional war

    Source: United Nations (Video News)

    Khaled Mohamed Khiari of Tunisia, Assistant Secretary-General for Middle East, Asia and the Pacific, urges an end to military activities in the Middle East to avert an all-out regional war. He also decries the unbearable conditions facing Palestinians in Gaza, where levels of death and destruction are harrowing. And he warned that thousands of children are at risk of polio because the vaccination campaign has been suspended.

    https://www.youtube.com/watch?v=HBHZjlypLm8

    MIL OSI Video –

  • MIL-OSI USA: Rep. Rosendale Introduces University Forced Vaccination Student Injury Mitigation Act

    Source: United States House of Representatives – Representative Matt Rosendale (Montana)

    WASHINGTON, D.C. – Today, Congressman Matt Rosendale (MT-02) introduced the University Forced Vaccination Student Injury Mitigation Act, which will require higher education institutions to pay the medical costs for any student who was required or is currently required to take a COVID-19 vaccine to attend classes and experienced an adverse reaction. The higher education institutions would lose all federal funds from the Department of Education if they do not comply with the requirements set out in the bill. The University Forced Vaccination Student Injury Mitigation Act is cosponsored by Congressman Eli Crane (AZ-02) and Congressman Bill Posey (FL-08), has received support from No College Mandates, and Dr. Joseph Marine who is Section Chief of Cardiology at Johns Hopkins Community Physicians.

    Washington Examiner published an exclusive article highlighting new legislation. You can see the story by clicking on the image below.

    “If you are not prepared to face the consequences, you should have never committed the act,” Rep. Rosendale said, “Colleges and universities forced students to inject themselves with an experimental vaccine knowing it was not going to prevent COVID-19 while potentially simultaneously causing life-threatening health defects like Guillian-Barre Syndrome and myocarditis. It is now time for schools to be held accountable for their brazen disregard for students’ health and pay for the issues they are responsible for causing.”

    “No student in the United States should face crippling medical costs because of an experimental vaccine their school forced them into receiving. We must hold institutions to account for continuing to inflict COVID-era idiocy on their student body, and that’s exactly what this bill would accomplish. I’m proud to be a cosponsor of this legislation to help rectify this unjustified overreach,” said Rep. Eli Crane.

    “College students were never at risk of severe injury or death from any variant of the COVID-19 virus and institutions of higher education had this data well in advance of mandating COVID-19 vaccines. Yet in the spring of 2021, college students were stripped of their fundamental right to bodily autonomy and informed consent when colleges imposed some of the most coercive and restrictive vaccination policies. Countless college students have been injured by COVID-19 vaccinations, and we are grateful that Representative Matthew Rosendale is introducing a new bill to hold colleges accountable for the injuries their unnecessary, unethical and unscientific policies have caused for without such legislation, these students and their families would have no other recourse,” said Lucia Sinatra, co-founder of No College Mandates.

    “COVID-19 vaccine mandates for college students were flawed policies that did not alter the course of the pandemic and were not needed to keep college campuses “safe.” I had to make efforts to prevent my own high school and college age children from receiving COVID-19 booster shots that they did not want or need. It seems reasonable to me that institutions that implemented such policies without a sound medical or scientific rationale should take responsibility for any proven medical harm that they caused,” said Joseph Marine, MD, MBA, FACC, FHRS, Section Chief of Cardiology, Johns Hopkins Community Physicians.

    MIL OSI USA News –

  • MIL-OSI USA: Durbin Delivers Opening Statement During Senate Judiciary Committee Field Hearing In Chicago On Reducing Prescription Drug Costs

    US Senate News:

    Source: United States Senator for Illinois Dick Durbin
    10.29.24
    CHICAGO – U.S. Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, today delivered an opening statement at the Senate Judiciary Committee field hearing in Chicago, Illinois, entitled “Reducing Prescription Drug Prices:  How Competition Can Make Medications Affordable for Patients.” The hearing includes two witness panels, including Members of Congress from Illinois and advocates for prescription drug pricing reform, to examine recent legislative successes to address anti-competitive tactics that make medications unaffordable for patients.
    Key Quotes:
    “Today the Committee will examine an issue on the minds of many in Illinois and across the country: the high price of prescription drugs.  It is a scandalous situation in America.  People in the United States pay the highest prescription drug prices in the world—on average, four times more than people in similar countries pay for brand-name medications.” 
    “For example: [when] the blood thinner Eliquis entered the market in 2013, it cost $3,100 annually in the U.S.  Same drug for sale in Japan [was] $1,000.  And, over the past decade, the price in the U.S. has more than doubled, from $3,100 to $7,100.  Meanwhile, in Japan, the price has dropped… Why?  For years, Big Pharma has abused our patent system to obtain monopolies on their medications, so they can charge these sky-high prices.” 
    “At the same time, they have spent billions of dollars to fill the airwaves with ads so patients tell their doctors they need drugs like Eliquis so they can go skiing, fishing, and whitewater rafting.   By fueling demand for expensive medications that are walled-off from competition by clever patent schemes, Big Pharma has made American patients their profit engine.”
    “Thankfully, this Administration and Democrats in Congress decided to do something about it.  In 2022, Congress passed, and President Biden signed into law the Inflation Reduction Act.  Not a single Republican voted for it.  Under this law, we have capped the price of insulin at $35 per month, saving 50,000 seniors in Illinois approximately $500 a year.  We have made vaccines under Medicare free.  When the shingles or RSV vaccines can cost up to $300 per dose, this change creates real savings for 1.4 million seniors in Illinois.  Starting in January, there will be a $2,000 annual cap on out-of-pocket costs for seniors—meaning, no matter how expensive your medications are, you will not pay more than $2,000 in co-pays per year.”
    “In August, the Biden-Harris Administration negotiated with Big Pharma to lower prices for 10 of the most expensive drugs under Medicare, resulting in price savings of up to 79 percent… As a result of this negotiation, nine million seniors will save a total of $1.5 billion in annual out-of-pocket costs—including nearly 300,000 seniors in Illinois who take one of these ten drugs.  Remember Eliquis?  Thanks to this new law, Medicare was able to permanently cut its price in half—taking nearly $300 off the monthly price tag—for more than 100,000 seniors in Illinois.”
    “But just as these historic savings are starting to take effect, there are real threats to our progress.  Eight pharmaceutical companies raced to federal courthouses to stop this price negotiation.  And former-President Trump and his Republican allies want to repeal this provision all together.”
    “Too often, the prices Big Pharma charges do not reflect scientific breakthroughs but, rather, manipulation by its lawyers and marketers.  In fact, the top 10 best-selling drugs in 2021 were covered by an average of 42 active patents that block competition and create windfall profits.”
    “The Judiciary Committee has taken a leading role in addressing Big Pharma’s schemes.  Last year, the Committee unanimously reported five bipartisan bills that addressed the industry’s anticompetitive tactics.  This includes my bill with Senator Tillis to improve information sharing between the FDA and Patent Office to prevent gamesmanship. Congress needs to pass these bills into law.”
    “Drugs are not effective in treating disease if a patient cannot afford to buy them.  Our hearing today will explore how legislation like the Inflation Reduction Actand the Judiciary Committee bills can help ensure every patient can access lifesaving medications.”
      
    Video of Durbin’s opening statement is available here.
    Audio of Durbin’s opening statement is available here.
    Footage of Durbin’s opening statement is available here for TV Stations.
    The United States has the highest prescription drug prices in the developed world, on average nearly four times higher than what other countries pay for some of the most common brand-name medications. Despite claims that these prices are necessary to fund research and development into the next generation of drugs, research suggests that the majority of innovation is driven by smaller companies, as well as taxpayer funding through the National Institutes of Health. The Committee has jurisdiction over competition issues and the intellectual property system, which play critical roles in incentivizing true innovation and protecting a healthy market that keeps prices for prescription drugs within reach of the patients that need them.
    Durbin, Senate Democrats, and the Biden-Harris Administration have taken numerous steps to lower the costs of prescription drugs. Democrats’ Inflation Reduction Actprovided the Administration the authority to negotiate drug prices with Big Pharma, which has already resulted in price reduction of up to 79 percent for 10 of the most expensive and frequently-dispensed prescription drugs for seniors.
    Earlier this Congress, a package of bills advanced unanimously out of the Committee to lower prescription drug prices and are awaiting a vote in the full Senate, including the Interagency Patent Coordination and Improvement Act introduced by U.S. Senators Dick Durbin (D-IL) and Thom Tillis (R-NC).
    Additionally, Durbin held a full committee hearing in May that scrutinized pharmaceutical companies’ abuse of the Orange Book and examined prescription drug prices, competition, and how to ensure medications are accessible and affordable for patients.
    -30-

    MIL OSI USA News –

  • MIL-OSI Video: UNICEF urges polio vaccination to resume in northern Gaza | United Nations

    Source: United Nations (Video News)

    ‘Polio can kill’, Rosalia Bollen of UNICEF warned, stressing that the second phase of the vaccination campaign urgently needs to be allowed to proceed in northern Gaza. The mid-November deadline is critical for about 120,000 children in Gaza and beyond.

    https://www.youtube.com/watch?v=ofC49K41f_k

    MIL OSI Video –

  • MIL-OSI USA: DeLauro Statement on Israel Banning UNRWA

    Source: United States House of Representatives – Congresswoman Rosa DeLauro (CT-03)

    Today, Congresswoman Rosa DeLauro (CT-03) released a statement in response to Israel’s parliament passing legislation to ban the United Nation’s Relief and Works Agency for Palestine Refugees in the Near East (UNRWA):

    “The United Nations Relief and Works Agency (UNRWA) is indispensable in addressing Gaza’s humanitarian crisis, as well as maintaining stability in the West Bank. Israel’s decision to enact legislation to halt UNRWA operations and cease all cooperation is dangerous, short-sighted, and would leave innocent Palestinians even more vulnerable to the devastating impacts of this war. At a time when we are already failing to meet the urgent needs of Gazans, this action further undermines UNRWA, fosters distrust in our international institutions, and fuels animosity toward Israel from its neighbors. This crisis is costing far too many innocent lives, including at least 60 people – mostly women and children – killed in a single strike on Tuesday in northern Gaza. The toll on civilian lives is tragic and underscores the need for uninterrupted humanitarian support.

    “As nearly 2 million Gazans continue to face starvation, this action would intensify an already dire crisis. It further threatens the health of Gazans, interrupting vital healthcare efforts, such as the World Health Organization’s polio vaccination campaign, which depends on UNRWA infrastructure and support and Israeli cooperation. Further destabilized Palestinian communities and friction with the United Nations jeopardizes regional security and isolates Israel globally.

    “UNRWA must be able to continue its lifesaving work. The agency has expressed commitment to working with Israel to ensure that its operations are not used by Hamas.  Our focus should be placed on the proposed reforms laid out in the Colonna Report to ensure the organization’s neutrality in a difficult working environment, not scapegoating a critical humanitarian actor.

    “Achieving peace and stability in the region requires an immediate ceasefire, a dramatic increase in humanitarian aid reaching civilians in need, and the release of the hostages held by Hamas.”

    MIL OSI USA News –

  • MIL-OSI USA: ICYMI: Tuberville in the Daily Caller: The Dangerous Biden-Harris Plan to Leave Our Veterans Behind

    US Senate News:

    Source: United States Senator for Alabama Tommy Tuberville
    “As one VA provider pointed out, this delay in critical healthcare could put us on the path to a ‘mass casualty event.’”
    WASHINGTON – Today, U.S. Senator Tommy Tuberville (R-AL) penned an op-ed in the Daily Caller about how the Biden-Harris administration is limiting community care access for veterans. Community care is essential to veterans across the country, specifically those in rural areas. In the piece, Senator Tuberville calls for slashing the bureaucratic red tape keeping veterans from receiving the pivotal care they deserve and emphasizes the need to change course before it is too late.
    Read excerpts from the piece below or here. 
    “Over the last four years, the Biden-Harris administration has made it clear its priorities lie anywhere but with America’s military service members.
    It was apparent in the disastrous Afghanistan withdrawal that left 13 service members dead. It was obvious when the Department of Defense forced extreme DEI requirements on our troops and discharged service members who had legitimate concerns about taking the COVID-19 vaccine.
    We hear it time and again with the White House’s rhetoric that now has us teetering on the brink of another World War — an event which would drag our sons and daughters into more foreign wars on behalf of interests that are not our own. 
    Which is why it comes as no surprise that the Biden-Harris administration is severely limiting veterans’ access to timely care. Access to community care is an essential health care option that can meet the various needs and circumstances for our veterans — especially those living in rural areas.
    The Community Care Network allows veterans to seek care from a provider who may be closer to the veteran in proximity than the nearest Department of Veterans Affairs (VA) facility, or who may have a shorter wait time than a comparable provider in the VA. It’s something that the brave men and women who have served our country need more access to, not less.”
    Senator Tommy Tuberville represents Alabama in the United States Senate and is a member of the Senate Armed Services, Agriculture, Veterans’ Affairs, and HELP Committees.

    MIL OSI USA News –

  • MIL-OSI Australia: Interview with Loretta Hart, 94.7 The Pulse

    Source: Australian Ministers 1

    LORETTA HART, HOST: As we celebrate 50 years of community radio in Australia, we’re featuring women doing great things in the sector and those making an impact on it. One such woman is my next guest, someone who is a champion for all things community broadcasting, the Honourable Michelle Rowland, Minister for Communications. Welcome to the program.

    MICHELLE ROWLAND, MINISTER FOR COMMUNICATIONS: Great to be with you. 

    HART:  And we’ve also been joined by Libby Coker in the studio as well, our Federal Member for Corangamite. Welcome, Libby.

    LIBBY COKER, FEDERAL MEMBER FOR CORANGAMITE: Welcome to you too. It’s great to be with you.

    HART: And look, I can’t go past that we actually got our station manager. Leo. Leo, welcome back from long service leave.

    LEO RENKIN, 94.7 STATION MANAGER: Thank you, Loretta. It’s been a very entertaining first day.

    HART: Absolutely. So, Michelle, you know, we know that the Labor Government introduced community radio back in the ‘70s. Can you share with us the importance of community broadcasting and radio, what- the importance it holds for the Government of today?

    ROWLAND: It’s absolutely an essential part of our media ecosystem, and I think it is opportune to reflect when Gough Whitlam started community broadcasting 50 years ago, it was referred to as experimental. So this was a step into the unknown about what can be done with this very valuable resource we call spectrum. I think it was one of the wisest moves that’s been made in communications regulation in this country, because where community broadcasting fits in in this whole ecosystem is it provides the heavy lifting that’s been done on media diversity. We are one of the most concentrated media ownership markets in the world, and to have hundreds of community broadcasters right around Australia serving localism, supported by volunteers, having connections with community.

    I’m really privileged to be here, just seeing the connections that you have with individuals, with community, how you reflect the local area. You try and think of another media format that can do that. You can’t. You can’t do it on a digital platform. You can’t do it in a profit making commercial broadcasting sense. It’s done through people who want to make a difference. Meeting Marwa, earlier from Syria, one of your stars. Clearly, that’s been life changing for her and she’s found a place here. I just think that says it all. It says everything about community broadcasting, community radio. It really does bring people together. Congratulations to The Pulse for clearly doing it so well. You really are the epitome of why we support this sector.

    HART:  Thank you so much. You used the word experimental, and I know we’re 50 years on, but I would say it still feels experimental. We have this opportunity to bring in new voices, to try new things to be nimble, which is such an exciting place for us to be. I’m wondering, Michelle, you know, as we move into this on demand lifestyle, I watch everything these days on – when it suits me on the TV, people are into their podcasts. Where do you see community radio fitting into this on demand space?

    ROWLAND: I think community radio is going to continue to innovate. Everyone thought radio was going to die with the advent of the iPod and then the iPhone, but community radio has really still found its place. You can find the app; you can listen to it anywhere you want. We’ve introduced a prominence framework in Australia as well to make local content easier to find. I think that the sector will continue to adapt, and I think it does it through two ways. Firstly, it is that local element, but it also is able to connect. It’s two-way. It’s not television. It’s two-way. When you have those personalities that are able to engage, continue to innovate through innovations like podcasting. Podcasting is one of those things, you know, it took off a few years ago, as did- we saw it with the ABC developing iView to have a library. Community broadcasting is doing the same thing, and it’s that kind of innovation that is going to keep it strong. But the key thing here, I’m sure Libby will agree, you need people. You need people, which goes to the whole reason why we’re doing the first really deep sustainability dive into the sector. You can’t operate for profit, but sponsorships are harder to come by. Volunteerism is on the decline, that’s just a fact. So we’ve got to look at new ways of support, and you’ve got to be able to attract people to be part of this. You’re doing it so well here. I could tell as soon as I walked in – you’re very lucky, Libby, to be representing such a special electorate.

    COKER: Yeah. Thanks, Michelle. I’m very fond of The Pulse. It’s been a place where people can come together and it fills a unique niche in this region. We have commercial radio, but we are also quite limited in our range of media. So if you want to have an in-depth interview on an issue, you really need to come to The Pulse to do that. I wish you all the best, and hope you continue to go from strength to strength and be here for another 50 years. It’s an impressive effort.

    HART:  Thank you, Libby. We will hold you to helping us.

    COKER: Yes, I know you will.

    LEO RENKIN CO-HOST: Just one thing that we haven’t really mentioned is the people who go on from the community radio station as well. Like we have Stefan, who’s gone back to Serbia and now presents TV over there. We also have Michelle Rimmer, you might see who’s an ABC reporter over in the UK – they all get their start somewhere like here. It’s very important because most commercial stations and there’s very limited opportunities at the ABC to get experience, and without it, there would be a lot of people who couldn’t go on and make a career out of radio. I think it’s one of the most underrated, important things that happen, not only radio, TV they go onto as well.

    HART: Couldn’t agree more.

    RENKIN: Yeah. That’s part of I think that thing is getting harder and harder to get experience, particularly for people in the media. I think that’s one of the things that we often forget about. You know, coming to a place like we’ve spoken about Marwa this morning, coming to a place where you can then get a chance to go ahead and do those things in media. Without it, as you mentioned before, it’s not a very diverse sector in the media field.

    ROWLAND: I think it’s great that people who are in community broadcasting, like Rove McManus, you know, he got his start on community TV. They go on to great things. But we also want them to stay.

    RENKIN: Exactly.

    ROWLAND: To nurture others as well. So it becomes a virtuous cycle.

    RENKIN: That’s right. They get picked very quickly, yeah.

    HART:  That’s right. I keep telling Marwa not to be so good because SBS is going to find her. She’s our most downloaded program and does an amazing job for her community. But I think that’s right. I mean, and we’re really proud of the links that we’re making with Deakin to support young journalists, students, and those in communications and marketing to come in. I want to give a shout out we had a young man, Cooper Watkins. Cooper came and did an eight-week intro to broadcasting program with us. Just on the weekend, he hosted an hour program with three interviews, and then on Monday, did six interviews for a two-hour program. And he’s just finished his journalism degree. But he is eager to get his hands on these buttons, to get behind the microphone and to get experience.

    So you’re right, Leo. I think that whilst we can have diverse voices, we can have underrepresented stories being given some air, but we’re also a training ground. But you’re right, Michelle, we want people to stay as well. Yeah.

    RENKIN: I’ve got Loretta chained to the desk actually.

    [Laughter]

    I think one of the underrated things about community radio is, like we’ve seen this morning, a diverse group of people coming together, and I think that’s very important for social cohesion as well. We often think of everyone in the community being different, but a place where they can come together and be different is a very special thing to have.

    ROWLAND: Couldn’t agree more.

    HART:  Michelle, just lastly, what can we look forward to- as community broadcasters, what can we look forward to the Albanese Government supporting and providing in this space?

    ROWLAND: Well, I want to reiterate that this is a government that doesn’t just say we support community broadcasting. We’ve backed that up with $23 million in funding. We want to continue to make sure that this sector remains strong. The first Bill I actually presented to the Parliament as Minister was on community broadcasting to help ease some of that regulatory burden. We have the sustainability review that’s being finalised by my Department now. I think it’s been really important to go out and to consult with the sector about what their needs are. When that comes through, I’m sure it will have some really practical suggestions in there for reform.

    But as Libby will tell you too, you know, we want to be judged on our delivery. It’s really something to be able to go to- I’ve lost count of how many community radio stations I’ve been to or have been on around Australia. But I want to be clear to your listeners. We’re a Government of delivery. We’re not afraid of the hard reforms. There are hard things happening in the media at the moment. This sector is under great challenge through the multinational digital platforms, under great stress through just the transition as well. It’s not the advertising market that it used to be. It is hard. There has to be that adaptation across mainstream media, but also by every part of the ecosystem, including community and just discussions today. This is an area that’s not without its challenges, even here in Geelong.

    But I can give you this commitment that we want to follow through on ensuring sustainability. We are going to have to make some hard decisions. But you can be assured that with good people like Libby backing you up in the Parliament as well, I think that this is a universally supported sector. It’s one that actually goes right across the aisle. You get people from regional areas and from metro areas who do support community radio. So I think that the proposals that we will put up, I’m confident that they’ll have strong support. There’s always a need to do more. Let’s be clear. I want to do expectations management. There’s always a need to do more. With hundreds of community radio stations across Australia with so many thousands of volunteers, we do have to remember I think come back to first principles. This is the fourth estate. It’s about making sure that authentic Australian voices, entertainment, and news get out there. We’re in an era of mis- and disinformation that is harmful to our democracy. This fourth estate that you support here is the front row of that fight against it. That’s one of the key reasons why I’m so passionate about it.

    RENKIN: Can I just add to that, Loretta?

    HART: Yeah, well, you can, but you’ve got 30 seconds.

    RENKIN: Sorry, 30 seconds. We found in COVID that we did have enormous amount of people come to us from different ethnic groups and want us to promote the vaccination programs and things that were going on because the only information they were referring to was online stuff, information from their own country. So for example, they were getting information from Croatia about what was going on, and then trying to think that was what was going to go on in Australia. Well, it was completely wrong. So we had some of our presenters come in and say, we have to get this message out, we have to get this message out. I think that’s one of the things that we- you know, when you said before about being the fourth pillar, I suppose, is that we can provide information from local community groups and for the local community groups, the best thing they know is word of mouth. And if it comes from one of the representatives, and then-

    ROWLAND: They trust. 

    RENKIN: They trust, exactly.

    HART:  They do indeed. It’s been a very fantastic conversation this morning. Thanks so much to Leo. Thanks very much to Libby Coker. And also thanks so much, Michelle, for being here, our Federal Minister for Communications. It’s been wonderful to have you in the studio with us.

    ROWLAND: Absolute pleasure.

    COKER: Thank you.

    MIL OSI News –

  • MIL-OSI Economics: Egypt marks major achievement with malaria-free certification, but need for global R&D remains significant, says GlobalData

    Source: GlobalData

    Egypt marks major achievement with malaria-free certification, but need for global R&D remains significant, says GlobalData

    Posted in Pharma

    The World Health Organization (WHO) has certified Egypt as being malaria-free, following a near 100-year endeavour by the Egyptian government. Egypt is the third country to be declared malaria-free in the WHO Eastern Mediterranean Region, and the 44th country globally. However, hundreds of millions of cases of malaria are still reported worldwide each year. These staggering numbers reinforce a global need for research and development, particularly for malaria vaccines, says GlobalData, a leading data and analytics company.

    Stephanie Kurdach, Infectious Disease Analyst at GlobalData, comments: “Egypt’s malaria-free certification is a significant achievement, as this is a country which once recorded millions of cases. Unfortunately, the global burden of malaria remains high.”

    The WHO reported nearly 250 million cases of malaria and over 600,000 malaria-related deaths worldwide in 2022.

    In order to be certified malaria-free by the WHO, a country must prove that there has been no local transmission of any human malaria parasites for at least the past three consecutive years. Additionally, a country must maintain a fully functional surveillance and response system to prevent the re-establishment of indigenous transmission.

    Egypt’s efforts to reduce mosquito-borne diseases began in the 1920s, when the country prohibited agricultural crops near homes. Other efforts over the past 100 years have included opening a malaria control station, recruiting thousands of healthcare workers, launching a public health surveillance project, and public education.

    Kurdach continues: “To address the global burden of malaria and work towards global eradication, research and development is critical. Just as Egypt remains obligated to maintain surveillance, diagnosis, and treatment efforts throughout the nation, other nations plagued by malaria are in dire need of robust surveillance systems, diagnostic tools, affordable health care, and malaria vaccines.”

    There are currently only two malaria vaccines which are WHO prequalified* and recommended for use in children: GSK’s Mosquirix and Serum Institute of India’s R21/Matrix-M.

    According to GlobalData, there are 12 other malaria vaccines currently in Phase II development, including vaccines from BioNTech, GSK, the National Institute of Allergy and Infectious Diseases (NIAID), and the University of Oxford. No new malaria vaccines are in Phase III development or pre-registration.

    Kurdach concludes: “There is a serious global unmet need for malaria vaccines, which is evidenced by the late-stage development pipeline. Egypt’s malaria-free certification serves as a reminder and call to action that malaria elimination is possible with increased research and development.”

    *The recommendations of Mosquirix and R21/Matrix-M by the WHO are relatively recent and occurred in 2021 and 2023, respectively.

    MIL OSI Economics –

  • MIL-OSI Russia: The number of users of the My ID service has doubled since the beginning of 2024

    Translation. Region: Russian Federation –

    Source: Moscow Government – Government of Moscow –

    Mobile application “My id” is becoming increasingly popular among Muscovites. Since the beginning of this year alone, the number of users has more than doubled. It now exceeds 125 thousand people.

    In the capital Department of Information Technology noted that the demand for the application is growing due to the constant expansion of its capabilities.

    “Since the launch of “My ID”, the number of documents whose information can be viewed in it has increased by 1.5 times. For example, a digital certificate of a large family has become available in the application, which can be presented to confirm the privileged status. At the same time, we continue to improve the already popular services of the application. Thus, recently, pet owners have the opportunity not only to view basic information about their pets, but also to control the timing of vaccinations and treatment, as well as quickly proceed to an appointment at a state veterinary clinic directly from the application,” the press service of the department said.

    With the My ID app, city residents can be sure that the necessary information will always be at hand. Currently, 14 types of documents and services are available in the app, including information on Russian and foreign passports, taxpayer identification numbers, birth certificates, SNILS, and others. This simplifies filling out various applications and online forms, and also allows sending information to trusted persons.

    In addition, the application provides digital versions of some documents, including a compulsory medical insurance policy, a single library card, and a large family certificate. They can be used to obtain various city services. For example, the barcode of the single library card from the application can be presented in the capital’s libraries to borrow and return books, and the QR code of the digital certificate of a large family will allow you to confirm your privileged status, for example, when buying tickets in the capital’s cultural institutions.

    Any registered user of the mos.ru portal can use the application – just log in to the application using your account. In the settings, the user can independently select the documents that he wants to use. The information specified by the user in the personal account or provided when receiving government services will be automatically displayed in the application.

    The mobile application “My id” is developing Department of Information Technology of the City of Moscow together with the State Institution “New Management Technologies”.

    The use of digital technologies and artificial intelligence to improve the quality of life of city residents corresponds to the objectives of the national program “Digital Economy of the Russian Federation” and the regional project of the capital “Digital Public Administration”. More information about this and other national projects implemented in Moscow can be found Here.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    Please note; This information is raw content directly from the information source. It is accurate to what the source is stating and does not reflect the position of MIL-OSI or its clients.

    https://vvv.mos.ru/nevs/item/145916073/

    MIL OSI Russia News –

  • MIL-OSI Global: RFK Jr.’s pivot to Trump is a journey taken by many populists swept along the left-to-right alternative media pipeline

    Source: The Conversation – USA – By Rachel Meade, Lecturer of Political Science, Boston University

    When Robert F. Kennedy Jr. ended his independent presidential run in August 2024 and endorsed Republican Donald Trump, it might have seemed a surprising turn of events.

    Kennedy began his presidential run as a Democrat and is the scion of a Democratic dynasty. Nephew to former President John F. Kennedy and the son of former Attorney General Robert F. Kennedy, Kennedy spent most of his career as a lawyer representing environmental groups that sued polluting corporations and municipalities.

    Yet Kennedy, 70, has long held positions that put him at odds with the Democratic mainstream. He pushes public health misinformation around vaccines and HIV/AIDS, opposes U.S. military involvement in foreign wars, including in Ukraine, and claims that the CIA assassinated his uncle.

    Kennedy’s ideologically mixed politics are hard to categorize in traditional left-right terms.

    My political science research finds that Kennedy’s journey from left-aligned skepticism into Trumpism is part of a broader trend of contemporary left-to-right populist transformations happening across the United States.

    Rise of the populist alternative media

    Populism is a political story that presents the good “people” of a nation as in a struggle against its “elites,” who have corrupted democratic institutions to further their own selfish interests. It cuts across the ideological spectrum, often combining left-wing economic critiques with right-wing cultural ones.

    Based on my research, I find that Kennedy uses a populist style of speech that matches the rhetoric of today’s online alternative media, also known as the “alternative influence network.”

    If populism cuts across the ideological spectrum, so does the alternative media.

    This network of politically diverse independent podcasters, YouTube hosts and other creators connects with young, politically disaffected audiences by mixing politics with comedy and pop culture, and presenting themselves as embattled defenders of free thinking – in opposition to mainstream media and mainstream parties.

    Top-rated shows include “Breaking Points,” “Stay Free with Russell Brand,” “The Joe Rogan Experience,” The Culture War with Tim Pool and “This Past Weekend w/ Theo Von.”

    While many of these shows have been around since the 2010s, the network expanded throughout the Trump era. Their popularity skyrocketed during the COVID-19 pandemic, when public distrust in government, anger over pandemic restrictions and vaccine skepticism surged.

    These shows hosted Kennedy frequently throughout his presidential run in 2023 and 2024.

    Kennedy finds his audience

    I analyzed a set of Kennedy’s appearances for this story. Both Kennedy and alternative media hosts claim to care about “the real issues” facing Americans such as war, corporate and political malfeasance and economic troubles. They condemn the “mainstream” for promoting frivolous “culture war” topics related to race and identity politics.

    Kennedy and the alternative media hosts also combine left and right arguments in a typically populist way. They claim that corporations control the government and that liberals and corporations censor free speech.

    For example, on a May 2024, episode of “Stay Free with Russell Brand,” Brand asserted that corrupt institutions are backed by the “deep state.” He asked Kennedy how he would fight these powerful interests.

    “The major agencies of government have all been captured by the industries they’re supposed to regulate and act as sock puppets serving the mercantile interests of these big corporations,” responded Kennedy. “I have a particular ability to unravel that because I’ve litigated against so many of these agencies.”

    My research found that Kennedy often bonded with his alternative media hosts over his perception that liberal media sources – allegedly controlled by the Democratic National Committee or the CIA – were censoring his campaign.

    Like Kennedy, alternative media hosts often identify as former or disaffected Democrats. Many used to work at mainstream left news sites, where they say they experienced censorship.

    ‘This little island of free speech’

    In a June 2023 episode of “The Joe Rogan Experience,” Rogan explained that he no longer identifies as a liberal because of the “orthodoxy it preaches” around issues like vaccines. He then cited YouTube’s removal of some of Kennedy’s vaccine-related videos for violating its COVID-19 misinformation policy.

    Kennedy had just spent 90 minutes outlining his journey toward vaccine skepticism, which started with meeting a mother who believed vaccines caused her son’s autism.

    “If a woman tells you something about her child, you should listen,” he said.

    Kennedy also described being convinced by a set of studies that public health officials had ignored.

    “Trust the experts is not a function of science, it’s a function of religion,” he said. “I’ve been litigating 40 years; there’s experts on both sides.”

    Afterward, he thanked Rogan for maintaining “this little island of free speech in a desert of suppression and of critical thinking.”

    Kennedy reiterated this point in the Aug. 23, 2024, speech that ended his campaign, saying the “alternative media” had kept his ideas alive, while the mainstream networks had shut him out despite his historically high third-party poll numbers of 15% to 20%.

    “The DNC-allied mainstream media networks maintained a near-perfect embargo on interviews with me,” Kennedy said.

    Speaking directly to the reporters in the room, he added, “Your institutions and media made themselves government mouthpieces and stenographers for the organs of power.”

    Left-to-right pipeline

    Trust in a range of U.S. institutions is at historical lows. Americans on both the right and the left are skeptical of power and crave radical change.

    Alternative media hosts tap into this desire, helping to push some disaffected listeners down the same left-to-right pipeline that landed Kennedy in Trump’s orbit.

    Trump and his allies are adept at harnessing the power of the alternative media ecosystem. Trump has appeared on male-centric shows like “This Past Weekend w/ Theo Von and ”The Joe Rogan Experience,“ and he founded the alternative social media platform Truth Social.

    Trump’s former adviser Steve Bannon hosts an influential podcast called the “War Room” on another MAGA alternative media platform, Rumble. Known for its fiery populist rhetoric, the “War Room” broadcasts live for an astonishing 22 hours a week.

    Until recently, Democrats have largely embraced traditional media. During the first months of her 2024 presidential campaign, Vice President Kamala Harris appeared on CBS’ “60 Minutes,” ABC’s “The View” and MSNBC’s “Stephanie Ruhle.”

    Then, on Oct. 12, Harris appeared on “Call her Daddy.” Spotify’s second-most popular podcast, it has a young, female audience. Days later, she sat down for an interview with Fox News and is reportedly in talks to appear on Joe Rogan’s show.

    Kennedy might approve of all this aisle-crossing.

    “Step outside the culture war!” he tweeted in July 2024. “Step outside the politics of hating the other side!”

    Rachel Meade does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. RFK Jr.’s pivot to Trump is a journey taken by many populists swept along the left-to-right alternative media pipeline – https://theconversation.com/rfk-jr-s-pivot-to-trump-is-a-journey-taken-by-many-populists-swept-along-the-left-to-right-alternative-media-pipeline-236828

    MIL OSI – Global Reports –

  • MIL-OSI Global: Israel’s ban on UNRWA continues a pattern of politicizing Palestinian refugee aid – and puts millions of lives at risk

    Source: The Conversation – USA – By Nicholas R. Micinski, Assistant Professor of Political Science and International Affairs, University of Maine

    The Israeli parliament’s vote on Oct. 28, 2024, to ban the United Nations agency that provides relief for Palestinian refugees is likely to affect millions of people – it also fits a pattern.

    Aid for refugees, particularly Palestinian refugees, has long been politicized, and the United Nations Relief and Works Agency for Palestine Refugees, or UNRWA, has been targeted throughout its 75-year history.

    This was evident earlier in the current Gaza conflict, when at least a dozen countries, including the U.S., suspended funding to the UNRWA, citing allegations made by Israel that 12 UNRWA employees participated in the attack by Hamas on Oct. 7, 2023. In August, the U.N. fired nine UNRWA employees for alleged involvement in the attack. An independent U.N. panel established a set of 50 recommendations to ensure UNRWA employees adhere to the principle of neutrality.

    The vote by the Knesset, Israel’s parliament, to ban the UNRWA goes a step further. It will, when it comes into effect, prevent the UNRWA from operating in Israel and will severely affect its ability to serve refugees in any of the occupied territories that Israel controls, including Gaza. This could have devastating consequences for livelihoods, health, the distribution of food aid and schooling for Palestinians. It would also damage the polio vaccination campaign that the UNRWA and its partner organizations have been carrying out in Gaza since September. Finally, the bill bans communication between Israeli officials and the UNRWA, which would end efforts by the agency to coordinate the movements of aid workers to prevent unintentional targeting by the Israel Defense Forces.

    Refugee aid, and humanitarian aid more generally, is theoretically meant to be neutral and impartial. But as experts in migration and international relations, we know funding is often used as a foreign policy tool, whereby allies are rewarded and enemies punished. In this context, we believe Israel’s banning of the UNRWA fits a wider pattern of the politicization of aid to refugees, particularly Palestinian refugees.

    What is the UNRWA?

    The UNRWA, short for United Nations Relief and Works Agency for Palestine Refugees in the Near East, was established two years after about 750,000 Palestinians were expelled or fled from their homes during the months leading up to the creation of the state of Israel in 1948 and the subsequent Arab-Israeli war.

    Palestinians flee their homes during the 1948 Arab-Israeli war.
    Pictures from History/Universal Images Group via Getty Images

    Prior to the UNRWA’s creation, international and local organizations, many of them religious, provided services to displaced Palestinians. But after surveying the extreme poverty and dire situation pervasive across refugee camps, the U.N. General Assembly, including all Arab states and Israel, voted to create the UNRWA in 1949.

    Since that time, the UNRWA has been the primary aid organization providing food, medical care, schooling and, in some cases, housing for the 6 million Palestinians living across its five fields: Jordan, Lebanon, Syria, as well as the areas that make up the occupied Palestinian territories: the West Bank and Gaza Strip.

    The mass displacement of Palestinians – known as the Nakba, or “catastrophe” – occurred prior to the 1951 Refugee Convention, which defined refugees as anyone with a well-founded fear of persecution owing to “events occurring in Europe before 1 January 1951.” Despite a 1967 protocol extending the definition worldwide, Palestinians are still excluded from the primary international system protecting refugees.

    While the UNRWA is responsible for providing services to Palestinian refugees, the United Nations also created the U.N. Conciliation Commission for Palestine in 1948 to seek a long-term political solution and “to facilitate the repatriation, resettlement and economic and social rehabilitation of the refugees and the payment of compensation.”

    As a result, UNRWA does not have a mandate to push for the traditional durable solutions available in other refugee situations. As it happened, the conciliation commission was active only for a few years and has since been sidelined in favor of the U.S.-brokered peace processes.

    Is the UNRWA political?

    The UNRWA has been subject to political headwinds since its inception and especially during periods of heightened tension between Palestinians and Israelis.

    While it is a U.N. organization and thus ostensibly apolitical, it has frequently been criticized by Palestinians, Israelis as well as donor countries, including the United States, for acting politically.

    The UNRWA performs statelike functions across its five fields, including education, health and infrastructure, but it is restricted in its mandate from performing political or security activities.

    Initial Palestinian objections to the UNRWA stemmed from the organization’s early focus on economic integration of refugees into host states.

    Although the UNRWA officially adhered to the U.N. General Assembly’s Resolution 194 that called for the return of Palestine refugees to their homes, U.N., U.K. and U.S. officials searched for means by which to resettle and integrate Palestinians into host states, viewing this as the favorable political solution to the Palestinian refugee situation and the broader Israeli-Palestinian conflict. In this sense, Palestinians perceived the UNRWA to be both highly political and actively working against their interests.

    In later decades, the UNRWA switched its primary focus from jobs to education at the urging of Palestinian refugees. But the UNRWA’s education materials were viewed by Israel as further feeding Palestinian militancy, and the Israeli government insisted on checking and approving all materials in Gaza and the West Bank, which it has occupied since 1967.

    A protester is removed by members of the U.S. Capitol Police during a House hearing on Jan. 30, 2024.
    Alex Wong/Getty Images

    While Israel has long been suspicious of the UNRWA’s role in refugee camps and in providing education, the organization’s operation, which is internationally funded, also saves Israel millions of dollars each year in services it would be obliged to deliver as the occupying power.

    Since the 1960s, the U.S. – the UNRWA’s primary donor – and other Western countries have repeatedly expressed their desire to use aid to prevent radicalization among refugees.

    In response to the increased presence of armed opposition groups, the U.S. attached a provision to its UNRWA aid in 1970, requiring that the “UNRWA take all possible measures to assure that no part of the United States contribution shall be used to furnish assistance to any refugee who is receiving military training as a member of the so-called Palestine Liberation Army (PLA) or any other guerrilla-type organization.”

    The UNRWA adheres to this requirement, even publishing an annual list of its employees so that host governments can vet them, but it also employs 30,000 individuals, the vast majority of whom are Palestinian.

    Questions over links of the UNRWA to any militancy has led to the rise of Israeli and international watch groups that document the social media activity of the organization’s large Palestinian staff.

    In 2018, the Trump administration paused its US$60 million contribution to the UNRWA. Trump claimed the pause would create political pressure for Palestinians to negotiate. President Joe Biden restarted U.S. contributions to the UNRWA in 2021.

    While other major donors restored funding to the UNRWA after the conclusion of the investigation in April, the U.S. has yet to do so.

    ‘An unmitigated disaster’

    Israel’s ban of the UNRWA will leave already starving Palestinians without a lifeline. U.N. Secretary General António Guterres said banning the UNRWA “would be a catastrophe in what is already an unmitigated disaster.” The foreign ministers of Canada, Australia, France, Germany, Japan, South Korea and the U.K. issued a joint statement arguing that the ban would have “devastating consequences on an already critical and rapidly deteriorating humanitarian situation, particularly in northern Gaza.”

    Reports have emerged of Israeli plans for private security contractors to take over aid distribution in Gaza through dystopian “gated communities,” which would in effect be internment camps. This would be a troubling move. In contrast to the UNRWA, private contractors have little experience delivering aid and are not dedicated to the humanitarian principles of neutrality, impartiality or independence.

    However, the Knesset’s explicit ban could, inadvertently, force the United States to suspend weapons transfers to Israel. U.S. law requires that it stop weapons transfers to any country that obstructs the delivery of U.S. humanitarian aid. And the U.S. pause on funding for the UNRWA was only meant to be temporary.

    The UNRWA is the main conduit for assistance into Gaza, and the Knesset’s ban makes explicit that the Israeli government is preventing aid delivery, making it harder for Washington to ignore. Before the bill passed, U.S. State Department Spokesperson Matt Miller warned that “passage of the legislation could have implications under U.S. law and U.S. policy.”

    At the same time, two U.S. government agencies previously alerted the Biden administration that Israel was obstructing aid into Gaza, yet weapons transfers have continued unabated.

    Sections of this story were first used in an earlier article published by The Conversation U.S. on Feb. 1, 2024.

    The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

    – ref. Israel’s ban on UNRWA continues a pattern of politicizing Palestinian refugee aid – and puts millions of lives at risk – https://theconversation.com/israels-ban-on-unrwa-continues-a-pattern-of-politicizing-palestinian-refugee-aid-and-puts-millions-of-lives-at-risk-242379

    MIL OSI – Global Reports –

  • MIL-OSI Global: The ancient Irish get way too much credit for Halloween

    Source: The Conversation – USA – By Lisa Bitel, Dean’s Professor of Religion & Professor of History, USC Dornsife College of Letters, Arts and Sciences

    The Celtic festival of Samhain celebrates a time of year when the division between Earth and the otherworld collapses, allowing spirits to pass through. Matt Cardy/Getty Images

    This time of year, I often run across articles proclaiming Halloween a modern form of the pagan Irish holiday of Samhain – pronounced SAW-en. But as a historian of Ireland and its medieval literature, I can tell you: Samhain is Irish. Halloween isn’t.

    The Irish often get credit – or blame – for the bonfires, pranksters, witches, jack-o’-lanterns and beggars who wander from house to house, threatening tricks and soliciting treats.

    The first professional 19th-century folklorists were the ones who created a through line from Samhain to Halloween. Oxford University’s John Rhys and James Frazer of the University of Cambridge were keen to find the origins of their national cultures.

    They observed lingering customs in rural areas of Britain and Ireland and searched medieval texts for evidence that these practices and beliefs had ancient pagan roots. They mixed stories of magic and paganism with harvest festivals and whispers of human sacrifice, and you can still find echoes of their outdated theories on websites.

    But the Halloween we celebrate today has more to do with the English, a ninth-century pope and America’s obsession with consumerism.

    A changing of the seasons

    For two millennia, Samhain, the night of Oct. 31, has marked the turn from summer to winter on the Irish calendar. It was one of four seasonal signposts in agricultural and pastoral societies.

    After Samhain, people brought the animals inside as refuge from the long, cold nights of winter. Imbolc, which is on Feb. 1, marked the beginning of the lambing season, followed by spring planting. Beltaine signaled the start of mating season for humans and beasts alike on May 1, and Lughnasadh kicked off the harvest on Aug. 1.

    But whatever the ancient Irish did on Oct. 31 is lost to scholars because there’s almost no evidence of their pagan traditions except legends written by churchmen around 800 A.D., about 400 years after the Irish started turning Christian. Although they wrote about the adventures of their ancestors, churchmen could only imagine the pagan ways that had disappeared.

    A neopagan celebration of Samhain in October 2021.
    Wikimedia Commons, CC BY-SA

    An otherworld more utopian than terrifying

    These stories about the pagan past told of Irish kings holding annual weeklong feasts, markets and games at Samhain. The day ended early in northwestern Europe, before 5 p.m., and winter nights were long. After sundown, people went inside to eat, drink and listen to storytellers.

    The stories did not link Samhain with death and horror. But they did treat Samhain as a night of magic, when the otherworld – what, in Irish, was known as the “sí” – opened its portals to mortals. One tale, “The Adventure of Nera,” warned that if you went out on Samhain Eve, you might meet dead men or warriors from the sí, or you might unknowingly wander into the otherworld.

    When Nera went out on a dare, he met a thirsty corpse in search of drink and unwittingly followed warriors through a portal into the otherworld. But instead of ghosts and terror, Nera found love. He ended up marrying a “ban sídh” – pronounced “BAN-shee” – an otherworldly woman. But here’s the medieval twist to the tale: He lived happily ever after in this otherworld with his family and farm.

    The Irish otherworld was no hell, either. In medieval tales, it is a sunny place in perpetual spring. Everyone who lives there is beautiful, powerful, immortal and blond. They have good teeth. The rivers flow with mead and wine, and food appears on command. No sexual act is a sin. The houses sparkle with gems and precious metals. Even the horses are perfect.

    Clampdown on pagan customs

    The link between Oct. 31, ghosts and devils was really the pope’s fault.

    In 834, Pope Gregory IV decreed Nov. 1 the day for celebrating all Christian saints. In English, the feast day became All Hallows Day. The night before – Oct. 31 – became known as All Hallows Eve.

    Some modern interpretations insist that Pope Gregory created All Hallows Day to quell pagan celebrations of Samhain. But Gregory knew nothing of ancient Irish seasonal holidays. In reality, he probably did it because everyone celebrated All Saints on different days and, like other Popes, Gregory sought to consolidate and control the liturgical calendar.

    In the later Middle Ages, All Hallows Eve emerged as a popular celebration of the saints. People went to church and prayed to the saints for favors and blessings. Afterward, they went home to feast. Then, on Nov. 2, they celebrated All Souls’ Day by praying for the souls of their lost loved ones, hoping that prayers would help their dead relatives out of purgatory and into heaven.

    But in the 16th century, the Protestant rulers of Britain and Ireland quashed saints’ feast days, because praying to saints seemed idolatrous. Protestant ministers did their best to eliminate popular customs of the early November holidays, such as candle-lit processions and harvest bonfires.

    In the minds of ministers, these customs smacked of heathenism.

    A mishmash of traditions

    Our Halloween of costumed beggars and leering jack-o’-lanterns descends from this mess of traditions, storytelling and antiquarianism.

    Like our ancestors, we constantly remake our most important holidays to suit current culture.

    Jack-o’-lanterns are neither ancient nor Irish. One of the earliest references is an 18th-century account of an eponymous Jack, who tricked the devil one too many times and was condemned to wander the world forever.

    Supposedly, Jack, or whatever the hero was called, carved a turnip and stuck a candle in it as his lantern. But the custom of carving turnips in early November probably originated in England with celebrations of All Saints’ Day and another holiday, Guy Fawkes Day on Nov. 5, with its bonfires and fireworks, and it spread from there.

    Guy Fawkes Day, an annual celebration in Great Britain, features fireworks and bonfires and is observed on Nov. 5.
    Hulton-Deutsch Collection/Corbis via Getty Images

    As for ancient bonfires, the Irish and Britons built them to celebrate Beltaine, but not Samhain – at least, not according to the medieval tales.

    In 19th-century Ireland, All Hallows Eve was a time for communal suppers, games like bobbing for apples and celebrating the magic of courtship. For instance, girls tried to peel apples in one long peel; then they examined the peels to see what letters they resembled – the initials of their future husbands’ names. Boys crept out of the gathering, despite warnings, to make mischief, taking off farm gates or stealing cabbages and hurling them at the neighbors’ doors.

    Halloween with an American sheen

    Across the Atlantic, these customs first appeared in the mid-19th century, when the Irish, English and many other immigrant groups brought their holidays to the U.S.

    In medieval Scotland, “guisers” were people who dressed in disguise and begged for “soul cakes” on All Souls Day. These guisers probably became the costumed children who threatened – and sometimes perpetrated – mischief unless given treats. Meanwhile, carved turnips became jack-o’-lanterns, since pumpkins were plentiful in North America – and easier to carve.

    Like Christmas, Valentine’s Day and Easter, Halloween eventually became a feast of consumerism. Companies mass-produced costumes, paper decorations and packaged candy. People in Britain and Ireland blamed the Americans for the spread of modern Halloween and its customs. British schools even tried to quash the holiday in the 1990s because of its disorderly and demonic connotations.

    The only real remnant of Samhain in Halloween is the date. Nowadays, no one expects to stumble into a romance in the sí. Only those drawn to the ancient Celtic past sense the numinous opening of the otherworld at Samhain.

    But who’s to say which reality prevails when the portals swing open in the dark of Oct. 31?

    Lisa Bitel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. The ancient Irish get way too much credit for Halloween – https://theconversation.com/the-ancient-irish-get-way-too-much-credit-for-halloween-239801

    MIL OSI – Global Reports –

  • MIL-OSI United Kingdom: Astra Awards Celebrate Grassroots Innovation23 Oct 2024

    Source: United Kingdom – Royal Air Force

    The Astra Awards celebrated innovation, challenge, and improvement across the RAF at the RAF Museum in London on 17 October 2024.

    Astra is the RAF’s approach to grassroots innovation, which encompasses bureaucracy challenge and continuous improvement. The Astra Awards recognise some of the most inspirational people, ingenious ideas, and the incredible impact they’ve had on our operational output.

    Award Winners

    Astra Unit Award, sponsored by Fujitsu

    Winner: RAF Lossiemouth

    RAF Lossiemouth showcases the future of the Astra Network at a unit level. Enthusiastically grasping the direction to refocus Astra onto grassroots innovation, the team have already made a significant impact on the innovative mindset across the station. Proactively upskilling the existing Continuous Improvement personnel in unfamiliar areas such as additive manufacturing, computer-aided design, and virtual reality, the small team are already proving highly effective in all aspects of grassroots innovation. Positively impacting on people and the operational output across the unit, they are making best use of every asset and opportunity provided to them. To support their work, the team have created an exciting and engaging Astra Hub; a collaborative, innovative space that will allow the whole force to continue to deliver substantial benefits to RAF Lossiemouth and the RAF.

    Astra Innovation Award, sponsored by PA Consulting

    Winner: Project I2T

    Project IMMERSIVE INSTRUCTOR TRAINING, known as I2T, is designed to enhance the delivery of training to Qualified Helicopter Instructors and Qualified Helicopter Crewman Instructors. Significantly modernising the outdated system, the project delivers training using immersive 360-degree video courseware accessed via virtual reality headsets. Developed by Flt Lt Rich Keeling and Dr Jon Allsop at the Central Flying School, it is being implemented by RAF Shawbury to great effect. It is proving to complement the existing training programme and allows instructors to gain skills through repeatable virtual scenarios and error analysis. It bridges the gap between theoretical and real-world flying in a sustainable manner and helps to ensure effective instructors for future helicopter aircrew.

    Astra Challenge Award, sponsored by Boxxe

    Winner: Sergeant Becky Livesey

    Consistently championing change for the benefit of our whole force, Becky has been a driving force behind a challenge to amend outdated policy to support hundreds of individuals with shared parental responsibility. The previous policy only allowed leave to be shared between serving spouses, which did not reflect the changing nature of families and led to personal difficulties and an unstable environment for the children of Service personnel. Her challenge highlighted the negative impact of the policy and was integral to bringing about a significant change. The updated policy now allows leave to be transferred between serving personnel in all three Services who both have parental responsibility for a child, enabling them to use it for childcare purposes. The resulting increase in stability for Service children and the home environment cannot be underestimated, nor can its impact on retention and morale for our people.

    Astra Improvement Award, sponsored by QinetiQ

    Winner: RAF Brize Norton Air Mobility Force Dispatch Optimisation

    The consolidation of key enablers into a centralised dispatch centre at RAF Brize Norton has greatly enhanced communication, professional relationships, and overall efficiency, saving over 15 minutes for every flight from the busy main operating base. The relocation of the Meteorological Office, Jet Plans, and MSC has reduced unnecessary movement and transportation waste, streamlining workflow. The elimination of ‘nav bags’ and the centralisation of Electronic Flight Bags further minimised motion waste. Additionally, process duplication has been removed, reducing rework, and allowing crews to plan without interruption. Crews also save a further 6-8 minutes by no longer needing to visit Load Control, and aircrew now book transport directly, reducing delays. The project has delivered efficiencies for all stakeholders throughout the process.

    Astra Contribution to Operations Award, sponsored by the RAF

    Winner: F-35 Detachment Toolkit

    Recognising the need for rapid deployability in support of ACE, the RAF Marham team developed and delivered a deployable toolkit in support of the F-35 fleet. Employing Lean Six Sigma analysis and modelling high level tool usage across the fleet, they identified the full requirements to ensure the project would deliver a successful product. The team repurposed tools and test equipment from redundant issue centres, obtained funding for a laser etching machine, and procured mobile support units. Owing to their efforts, the F-35 now has a deployable tool capability that was used for the first time in the Iceland Air Policing operation. The capability has increased the potential operational output of the fleet, allowing it to operate effectively in two different locations with minimal impact to the flying programme.

    Astra Ambassador Award, sponsored by the RAF

    Winner: Chief Technician Martyn Sullivan

    Martyn has consistently demonstrated and embodied innovation, challenge, and improvement. His passion for making RAF Coningsby better through well-structured and benefit-led projects has ensured his small team have delivered a positive and lasting impact at unit level. Their demonstrable output adds value across the board. Alongside his commitment to RAF Coningsby, he actively collaborates with the whole force across the RAF, sharing his knowledge and experience and encouraging others to develop their innovative mindset. He created, organised, and delivered courses that developed an internal grassroots innovation network that spans all professions and sections. Furthermore, his exceptional work with industry partners such as BAE Systems has delivered projects that have improved and enhanced the operational output of the Typhoon fleet at both Coningsby and Lossiemouth.

    Spirit of Innovation Award, sponsored by BAE Systems

    Winner: Chief Technician Neil Hunt

    Wing Commander Williamson collected the award on behalf of Chief Technician Hunt. It will be formally presented on unit.

    Neil has shown significant determination and commitment to improvement. After identifying issues with the transportation of F-35 canopies across unit, Neil, alongside Sgt Richard James, developed the F-35 Canopy Transportation Trolley project, which has now been brought into service at RAF Marham. The innovative improvement project has already saved Defence over £600k. Continuing to engage with the Astra improvement process, Neil has submitted a further 13 ideas over the past two years. This includes the F-35 Ejection Seat Transportation Solution, which has once again delivered an effective solution that has delivered significant benefits, saving Defence £1.75m in the first 3 months by removing potential for damage and increasing resource efficiency.

    Neil’s award was collected by Wg Cdr Williamson on his behalf and will be handed over formally on unit.

    Astra Rising Star Award, sponsored by Frazer-Nash Consultancy

    Winner: Elizabeth Garvin

    Beth is new to the Civil Service and the RAF whole force as the Continuous Improvement Facilitator at RAF St Mawgan, who has taken on the role of Astra Ambassador as well as CI Lead. Always keen to learn, she proactively approached the Headquarters CI Team to secure a place on the Lean Six Sigma training course to further develop her skills. Since completing the course, she has rapidly applied her newfound knowledge and skills to delivering improvements across the unit. She has embraced the Astra ethos and amalgamated innovation, challenge, and improvement across all functional areas on unit, developing a growing innovative mindset and culture. Her creation of a regular drumbeat of collaboration opportunities, where she shares insight into activity in other areas, is already proving popular and igniting ideas in others from every area across the unit. Beth epitomises the values and intentions of Astra and grassroots innovation in the RAF whole force.

    Astra People’s Choice Award, sponsored by Babcock

    Winner: D-State Proforma

    Using the tools and techniques of Continuous Improvement, a full review and redesign of the State Demand form at RAF Coningsby was undertaken. The inefficient process saw at least 12 versions of the same form used on unit, with a significant administrative burden for all involved in submitting the 6000+ forms a year. The process was reviewed end-to-end and redesigned to remove unnecessary steps. Considering the needs of all stakeholders, it has simplified the communication flow and established an effective feedback loop. The project has significantly reduced the rejection rate for state demand forms and the potential misallocation of engineering spares. The redesigned form has also saved over 1600 hours per year just at RAF Coningsby and has also been used repeatedly and proven highly successful in the UK and on Op SHADER.

    Astra Team Award, sponsored by Leonardo

    Winner: Ailidh Leather

    Ailidh Leather has been the lead for Project POST ROOM at RAF Cosford, which uses scanning technology to significantly enhance the experience of the Post Room staff and the hundreds of recipients on station. Several years ago, Ailidh identified how technology could transform how mail is processed. With increasing amounts of parcels due to online shopping and inefficient handwritten ledgers, the post room was being swamped with mail leading to long delays in items reaching their intended recipient. Her persistence, determination, and forward thinking have ensured that the project has reached the position it is in today despite numerous setbacks. Through her tenacity, the project is making a real difference to the lives of personnel at Cosford, with potential to be rolled out wider across the RAF.

    Chief of the Air Staff’s Award, sponsored by Astra

    Winner: Air Specialist Class 1 Ross McGrory

    Ross played a pivotal role in Project GAIA, seamlessly transforming it into a Digital Shadow for a deployed medical centre by connecting multiple devices to a central hub. Proactively learning a new programming language, and dedicating a significant amount of his personal time, he developed a working product that provides a critical capability – 24/7 monitoring for emergency medical items such as blood supplies. Ross’s innovative mindset and skillset ensured that the complex system could easily be used by non-technical staff, which is not an easy task. Additionally, as second in command of RAF Leeming‘s Makerspace, which is an integral part of the Astra Hub, he expanded user engagement. He swiftly solved a persistent station issue in just 4 hours, highlighting his technical expertise and commitment to innovation.

    Hundreds gathered in Sunderland Hall at the RAF Museum for an evening of reward and recognition, showcasing grassroots innovation and sharing ideas. Grassroots innovation activities from the whole force were on display to ignite the innovative mindset of our people and encourage collaboration to bring meaningful change.

    Personnel from across the whole force were joined by international allies from the United States Air Force (USAF), Royal Australian Air Force, and Royal Canadian Air Force. Members of the USAF currently based in the UK also joined RAF personnel in demonstrating grassroots innovation projects in their area. The USAF’s AFWERX team are working closely with the RAF’s Astra Team to encourage collaboration on common problem sets, with the first joint grassroots innovation projects already being planned.

    MIL OSI United Kingdom –

  • MIL-OSI United Kingdom: RAF 60 Second UpdateWe’re celebrating our people in the latest RAF 60 Second Update, from the RAF Astra Awards.23 Oct 2024

    Source: United Kingdom – Royal Air Force

    We’re celebrating our people in the latest RAF 60 Second Update, from the RAF Astra Awards.

    In this episode:

    • The RAF Astra Awards recognise the fantastic people and projects that have contributed to grassroots innovation across the RAF in the last year.
    • The UK is the first nation to fly nearly the full length of NATO’s Eastern Flank with a Rivet Joint.
    • The first cohort of high potential aviators graduate from the new RAF LEAD development programme.

    Thanks for watching and see you next time!

    MIL OSI United Kingdom –

  • MIL-OSI USA: Biomedical Engineering Scientist Receives $1.5 Million General Medicine Grant

    Source: US State of Connecticut

    An accomplished bioengineering researcher at UConn’s College of Engineering (CoE) has received a $1.5 million National Institute of Health grant for his pioneering work in the field of computation-aided molecular design of DNA-inspired Janus Base Nanopieces (JBNps). These are a family of novel biomaterials that mimic DNA and are used in therapeutic and regenerative treatments for people with arthritis, cancer, and neurological diseases.

    “JBNps have a distinct advantage for delivery into ‘hard-to-penetrate’ tissues such as articular cartilage, solid tumors, kidneys and the central nervous system,” says Biomedical Engineering Associate Professor Yupeng Chen. “The impact in treatments will be significant.”

    Chen is the principal investigator and grant recipient, and is studying the impact of manipulating Messenger RNA (mRNA), a molecule that carries the genetic instructions from DNA in the cell nucleus to the ribosomes in the cytoplasm, where those instructions are used to build proteins.

    Essentially, Chen explains, mRNA acts like a “message carrier” to tell the cell which proteins to make.

    “We will develop a novel delivery technology by manipulating the bio-interface properties of the DNA-inspired Janus Base Nanopieces,” Chen says. “JBNps are slimmer than conventional spherical particles, allowing for enhanced infiltration into tissue matrices and barriers.”

    Messenger RNA, Chen adds, is the key ingredient in COVID-19 vaccines and anti-inflammatory drugs and offers the potential for myriad other applications. But there are numerous obstacles to overcome, he states. Unlike many chemical molecules or antibody proteins, mRNAs need to be delivered into cell cytoplasm to be functional. Various types of materials have been developed for successful intracellular delivery of small RNAs, but it is still a major challenge to achieve effective delivery of mRNAs at both cellular and systemic levels.

    Yupeng Chen (photo by Christopher LaRosa)

    Chen cites the study of arthritis as an example. Infiltrating articular cartilage, he says, poses a significant delivery challenge because its matrix has minuscule pore sizes. As a result, no disease-modifying drug exists to treat this condition. JBNps, he explains are smaller and more effectively shaped than the formulations currently being used. They are manufactured through the non-covalent assembly of Janus Bases, allowing researchers to control their formulations and properties by simply mixing different types of Janus Bases.

    “For instance, we can use sidechain-modified Janus Bases for endosomal escape, zwitterion-modified ones for improved biodistribution, and unmodified Janus Bases as the basic building blocks for mRNA loading,” Chen says. “Additionally, focusing on molecule-linked Janus bases can be used for tissue targeting. In this way, JBNps can be easily tailored for a variety of purposes. We expect to develop sidechain-modified JBNps for the most effective mRNA delivery to treat cartilage diseases such as arthritis.”

    Last year, Chen and a student team received international notoriety when NASA astronauts aboard the International Space Station (ISS) conducted an inflight, microgravity proof-of-concept study involving the fabrication of JBNps. During their experimentation, the astronauts communicated directly with Chen and some of his students via Axiom Space and Eascra Biotech as implementation and industry partners at their lab on the UConn campus in Storrs, Connecticut.

    During the course of this four-year grant, Chen will be working with Dr. Ying Li from the University of Wisconsin, an expert in multiscale computational modeling and machine learning; and Dr. Harvey Lodish from MIT, who will provide expertise in cell and RNA biology and therapeutic development. Their proposal, he adds, is built on successful preliminary results and recent publication in high-impact journals such as in PNAS, Science Advances, Angewandte Chemie, ACS Nano, Advanced Functional Materials, Biomaterials, Computational Mechanics, and others.

    MIL OSI USA News –

  • MIL-OSI: Eagle Bancorp Montana Earns $2.7 Million, or $0.34 per Diluted Share, in the Third Quarter of 2024; Declares Quarterly Cash Dividend of $0.1425 Per Share

    Source: GlobeNewswire (MIL-OSI)

    HELENA, Mont., Oct. 29, 2024 (GLOBE NEWSWIRE) — Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), (the “Company,” “Eagle”), the holding company of Opportunity Bank of Montana (the “Bank”), today reported net income of $2.7 million, or $0.34 per diluted share, in the third quarter of 2024, compared to $1.7 million, or $0.22 per diluted share, in the preceding quarter, and $2.6 million, or $0.34 per diluted share, in the third quarter of 2023. In the first nine months of 2024, net income was $6.3 million, or $0.81 per diluted share, compared to $7.9 million, or $1.01 per diluted share, in the first nine months of 2023.

    Eagle’s board of directors declared a quarterly cash dividend of $0.1425 per share on October 17, 2024. The dividend will be payable December 6, 2024, to shareholders of record November 15, 2024. The current dividend represents an annualized yield of 3.49% based on recent market prices.

    “We produced improved top and bottom line operating results during the third quarter of 2024, with net interest income and noninterest income both increasing compared to the second quarter of 2024,” said Laura F. Clark, President and CEO. “As in previous quarters, we continued to remain selective on the loans we added during the quarter, while adhering to disciplined loan pricing. The result was tempered loan growth during the third quarter of 1.1%, and 4.0% year-over-year. Total deposits increased 2.0% during the quarter over the linked quarter, as we continue to maintain our attractive deposit mix. With our strong deposit franchise, pristine credit quality, and ample capital levels, we are well positioned for growth throughout the remainder of the year and into 2025.”

    Third Quarter 2024 Highlights (at or for the three-month period ended September 30, 2024, except where noted):

    • Net income was $2.7 million, or $0.34 per diluted share, in the third quarter of 2024, compared to $1.7 million, or $0.22 per diluted share, in the preceding quarter, and $2.6 million, or $0.34 per diluted share, in the third quarter a year ago.
    • Net interest margin (“NIM”) was 3.34% in the third quarter of 2024, a seven basis point contraction compared to 3.41% in the preceding quarter and the third quarter a year ago.
    • Revenues (net interest income before the provision for credit losses, plus noninterest income) were $20.8 million in the third quarter of 2024, compared to $19.9 million in the preceding quarter and $21.6 million in the third quarter a year ago.
    • The accretion of the loan purchase discount into loan interest income from acquisitions was $167,000 in the third quarter of 2024, compared to accretion on purchased loans from acquisitions of $304,000 in the preceding quarter.
    • Total loans increased 4.0% to $1.53 billion, at September 30, 2024, compared to $1.48 billion a year earlier, and increased 1.1% compared to $1.52 billion at June 30, 2024.
    • Total deposits increased $35.0 million or 2.2% to $1.65 billion at September 30, 2024, compared to a year earlier, and increased $31.6 million or 2.0%, compared to June 30, 2024.
    • The allowance for credit losses represented 1.12% of portfolio loans and 356.7% of nonperforming loans at September 30, 2024, compared to 1.10% of portfolio loans and 209.3% of nonperforming loans at September 30, 2023.
    • The Company’s available borrowing capacity was approximately $348.1 million at September 30, 2024.
            September 30, 2024
    (Dollars in thousands)     Borrowings Outstanding Remaining Borrowing Capacity
    Federal Home Loan Bank advances $ 219,167 $ 219,365
    Federal Reserve Bank discount window   –   28,734
    Correspondent bank lines of credit   –   100,000
    Total       $ 219,167 $ 348,099
               
    • The Company paid a quarterly cash dividend in the second quarter of $0.1425 per share on September 6, 2024, to shareholders of record August 16, 2024.

    Balance Sheet Results

    Eagle’s total assets increased 4.0% to $2.15 billion at September 30, 2024, compared to $2.06 billion a year ago, and increased 2.2% compared to $2.10 billion three months earlier. The investment securities portfolio totaled $307.0 million at September 30, 2024, compared to $308.8 million a year ago, and $306.9 million at June 30, 2024.

    Eagle originated $58.0 million in new residential mortgages during the quarter and sold $51.0 million in residential mortgages, with an average gross margin on sale of mortgage loans of approximately 3.31%. This production compares to residential mortgage originations of $60.6 million in the preceding quarter with sales of $53.2 million and an average gross margin on sale of mortgage loans of approximately 3.01%. Mortgage volumes remain low as rates have continued to be elevated relative to rates on existing mortgages.

    Total loans increased $58.9 million, or 4.0%, compared to a year ago, and $17.2 million, or 1.1%, from three months earlier. Commercial real estate loans increased 5.2% to $644.0 million at September 30, 2024, compared to $612.0 million a year earlier. Commercial real estate loans were comprised of 69.3% non-owner occupied and 30.7% owner occupied at September 30, 2024. Agricultural and farmland loans increased 5.8% to $290.0 million at September 30, 2024, compared to $274.1 million a year earlier. Residential mortgage loans increased 6.7% to $156.8 million, compared to $146.9 million a year earlier. Commercial loans increased 10.2% to $143.2 million, compared to $130.0 million a year ago. Commercial construction and development loans decreased 17.3% to $125.3 million, compared to $151.6 million a year ago. Home equity loans increased 12.5% to $93.6 million, residential construction loans increased 8.5% to $52.2 million, and consumer loans decreased 1.3% to $29.4 million, compared to a year ago.

    “Our deposit mix continued to shift towards higher yielding deposits due to the higher interest rate environment. However, we anticipate deposit rates will continue to stabilize or improve following the recent Fed rate cuts,” said Miranda Spaulding, CFO.

    Total deposits increased to $1.65 billion at September 30, 2024, compared to $1.62 billion at September 30, 2023, and at June 30, 2024. Noninterest-bearing checking accounts represented 25.4%, interest-bearing checking accounts represented 12.7%, savings accounts represented 12.9%, money market accounts comprised 21.3% and time certificates of deposit made up 27.7% of the total deposit portfolio at September 30, 2024. Time certificates of deposit include $22.1 million in brokered certificates at September 30, 2024, compared to $40.0 million at September 30, 2023, and $26.2 million at June 30, 2024. The average cost of total deposits was 1.76% in the third quarter of 2024, compared to 1.70% in the preceding quarter and 1.28% in the third quarter of 2023. The estimated amount of uninsured deposits was approximately $307.0 million, or 18% of total deposits, at September 30, 2024, compared to $284.0 million, or 17% of total deposits, at June 30, 2024.

    Shareholders’ equity was $177.7 million at September 30, 2024, compared to $157.3 million a year earlier and $170.2 million three months earlier. Book value per share increased to $22.17 at September 30, 2024, compared to $19.69 a year earlier and $21.23 three months earlier. Tangible book value per share, a non-GAAP financial measure calculated by dividing shareholders’ equity, less goodwill and core deposit intangible, by common shares outstanding, was $17.23 at September 30, 2024, compared to $14.55 a year earlier and $16.25 three months earlier.  

    Operating Results

    “Our core NIM declined slightly during the third quarter, compared to the preceding quarter, due to relatively flat yields on interest earning assets and cost of funds expansion,” said Clark. “We anticipate continued stabilization and eventual improvement in our cost of funds as we continue through this rate cycle.”

    Eagle’s NIM was 3.34% in the third quarter of 2024, a seven basis point contraction compared to 3.41% in both the preceding quarter and the third quarter a year ago. The interest accretion on acquired loans totaled $167,000 and resulted in a three basis-point increase in the NIM during the third quarter of 2024, compared to $304,000 and a seven basis-point increase in the NIM during the preceding quarter. Funding costs for the third quarter of 2024 were 2.89%, compared to 2.78% in the second quarter of 2024 and 2.37% in the third quarter of 2023. Average yields on interest earning assets for the third quarter of 2024 increased to 5.66%, compared to 5.64% in the second quarter of 2024 and 5.27% in the third quarter a year ago. For the first nine months of 2024, the NIM was 3.36% compared to 3.57% for the first nine months of 2023.

    Net interest income, before the provision for credit losses, increased to $15.8 million in the third quarter of 2024, compared to $15.6 million in both the second quarter of 2024, and in the third quarter of 2023. Year-to-date, net interest income decreased 1.3% to $46.6 million, compared to $47.3 million in the same period one year earlier.

    Revenues for the third quarter of 2024 increased 4.4% to $20.8 million, compared to $19.9 million in the preceding quarter and decreased 3.9% compared to $21.6 million in the third quarter a year ago. In the first nine months of 2024, revenues were $59.9 million, compared to $64.2 million in the first nine months of 2023. The decrease compared to the first nine months a year ago was largely due to lower volumes in mortgage banking activity.

    Total noninterest income increased 16.7% to $5.0 million in the third quarter of 2024, compared to $4.3 million in the preceding quarter, and decreased 17.4% compared to $6.0 million in the third quarter a year ago. The increase from the preceding quarter was largely due to income from bank owned life insurance of $724,000. Net mortgage banking income, the largest component of noninterest income, totaled $2.6 million in the third quarter of 2024, compared to $2.4 million in the preceding quarter and $4.3 million in the third quarter a year ago. This decrease compared to the third quarter a year ago was largely driven by a decline in net gain on sale of mortgage loans. This was impacted by lower mortgage loan volumes. In the first nine months of 2024, noninterest income decreased 21.9% to $13.2 million, compared to $16.9 million in the first nine months of 2023. Net mortgage banking income decreased 36.0% to $7.2 million in the first nine months of 2024, compared to $11.3 million in the first nine months of 2023. These decreases were driven by a decline in net gain on sale of mortgage loans.

    Third quarter noninterest expense was $17.3 million, which was unchanged compared to the preceding quarter and a 3.4% decrease compared to $17.9 million in the third quarter a year ago. Lower salaries and employee benefits contributed to the decrease compared to the year ago quarter. In the first nine months of 2024, noninterest expense decreased 3.0% to $51.6 million, compared to $53.2 million in the first nine months of 2023.

    For the third quarter of 2024, the Company recorded income tax expense of $529,000. This compared to income tax expense of $444,000 in the preceding quarter and $524,000 in the third quarter of 2023. The effective tax rate for the third quarter of 2024 was 16.3%, compared to 16.6% for the third quarter of 2023. The year-to-date effective tax rate was 17.5% for 2024 compared to 19.5% for the same period in 2023.

    Credit Quality

    During the third quarter of 2024, Eagle recorded a provision for credit losses of $277,000. This compared to a $412,000 provision for credit losses in the preceding quarter and $588,000 in the third quarter a year ago. The allowance for credit losses represented 356.7% of nonperforming loans at September 30, 2024, compared to 330.8% three months earlier and 209.3% a year earlier. Nonperforming loans were $4.8 million at September 30, 2024, $5.1 million at June 30, 2024, and $7.8 million a year earlier.

    Net loan charge-offs totaled $17,000 in the third quarter of 2024, compared to net loan charge-offs of $2,000 in the preceding quarter and net loan charge-offs of $108,000 in the third quarter a year ago. The allowance for credit losses was $17.1 million, or 1.12% of total loans, at September 30, 2024, compared to $16.8 million, or 1.11% of total loans, at June 30, 2024, and $16.2 million, or 1.10% of total loans, a year ago.

    Capital Management

    The ratio of tangible common shareholders’ equity (shareholders’ equity, less goodwill and core deposit intangible) to tangible assets (total assets, less goodwill and core deposit intangible) was 6.56% at September 30, 2024, from 5.75% a year ago and 6.33% three months earlier. As of September 30, 2024, the Bank’s regulatory capital was in excess of all applicable regulatory requirements and is deemed well capitalized. The Bank’s Tier 1 capital to adjusted total average assets was 9.87% as of September 30, 2024.

    About the Company

    Eagle Bancorp Montana, Inc. is a bank holding company headquartered in Helena, Montana, and is the holding company of Opportunity Bank of Montana, a community bank established in 1922 that serves consumers and small businesses in Montana through 29 banking offices. Additional information is available on the Bank’s website at www.opportunitybank.com. The shares of Eagle Bancorp Montana, Inc. are traded on the NASDAQ Global Market under the symbol “EBMT.”

    Forward Looking Statements

    This release may contain certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and may be identified by the use of such words as “believe,” “will” “expect,” “anticipate,” “should,” “planned,” “estimated,” and “potential.” These forward-looking statements include, but are not limited to statements of our goals, intentions and expectations; statements regarding our business plans, prospects, mergers, growth and operating strategies; statements regarding the asset quality of our loan and investment portfolios; and estimates of our risks and future costs and benefits. These forward-looking statements are based on current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. These factors include, but are not limited to, changes in laws or government regulations or policies affecting financial institutions, including changes in regulatory fees and capital requirements; general economic conditions and political events, either nationally or in our market areas, that are worse than expected including the ability of the U.S. Congress to increase the U.S. statutory debt limit, as needed, as well as the impact of the 2024 U.S. presidential election; the emergence or continuation of widespread health emergencies or pandemics including the magnitude and duration of the COVID-19 pandemic, including but not limited to vaccine efficacy and immunization rates, new variants, steps taken by governmental and other authorities to contain, mitigate and combat the pandemic, adverse effects on our employees, customers and third-party service providers, the increase in cyberattacks in the current work-from-home environment, the ultimate extent of the impacts on our business, financial position, results of operations, liquidity and prospects, continued deterioration in general business and economic conditions could adversely affect our revenues and the values of our assets and liabilities, lead to a tightening of credit and increase stock price volatility, and potential impairment charges; the impact of volatility in the U.S. banking industry, including the associated impact of any regulatory changes or other mitigation efforts taken by governmental agencies in response thereto; the possibility that future credit losses may be higher than currently expected due to changes in economic assumptions, customer behavior, adverse developments with respect to U.S. economic conditions and other uncertainties, including the impact of supply chain disruptions, inflationary pressures and labor shortages on economic conditions and our business; an inability to access capital markets or maintain deposits or borrowing costs; competition among banks, financial holding companies and other traditional and non-traditional financial service providers; loan demand or residential and commercial real estate values in Montana; the concentration of our business in Montana; our ability to continue to increase and manage our commercial real estate, commercial business and agricultural loans; the costs and effects of legal, compliance and regulatory actions, changes and developments, including the initiation and resolution of legal proceedings (including any securities, bank operations, consumer or employee litigation); inflation and changes in the interest rate environment that reduce our margins or reduce the fair value of financial instruments; adverse changes in the securities markets that lead to impairment in the value of our investment securities and goodwill; other economic, governmental, competitive, regulatory and technological factors that may affect our operations; our ability to implement new technologies and maintain secure and reliable technology systems including those that involve the Bank’s third-party vendors and service providers; cyber incidents, or theft or loss of Company or customer data or money; our ability to appropriately address social, environmental, and sustainability concerns that may arise from our business activities; the effect of our recent or future acquisitions, including the failure to achieve expected revenue growth and/or expense savings, the failure to effectively integrate their operations, the outcome of any legal proceedings and the diversion of management time on issues related to the integration.

    Because of these and other uncertainties, our actual future results may be materially different from the results indicated by these forward-looking statements. All information set forth in this press release is current as of the date of this release and the company undertakes no duty or obligation to update this information.

    Use of Non-GAAP Financial Measures

    In addition to results presented in accordance with generally accepted accounting principles utilized in the United States, or GAAP, the Financial Ratios and Other Data contains non-GAAP financial measures. Non-GAAP financial measures include: 1) core efficiency ratio, 2) tangible book value per share and 3) tangible common equity to tangible assets. The Company uses these non-GAAP financial measures to provide meaningful supplemental information regarding the Company’s operational performance and performance trends, and to enhance investors’ overall understanding of such financial performance. In particular, the use of tangible book value per share and tangible common equity to tangible assets is prevalent among banking regulators, investors and analysts.

    The numerator for the core efficiency ratio is calculated by subtracting acquisition costs and intangible asset amortization from noninterest expense. Tangible assets and tangible common shareholders’ equity are calculated by excluding intangible assets from assets and shareholders’ equity, respectively. For these financial measures, our intangible assets consist of goodwill and core deposit intangible. Tangible book value per share is calculated by dividing tangible common shareholders’ equity by the number of common shares outstanding. We believe that this measure is consistent with the capital treatment by our bank regulatory agencies, which exclude intangible assets from the calculation of risk-based capital ratios and present this measure to facilitate the comparison of the quality and composition of our capital over time and in comparison, to our competitors.

    Non-GAAP financial measures have inherent limitations, are not required to be uniformly applied, and are not audited. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies’ non-GAAP financial measures having the same or similar names. Further, the non-GAAP financial measure of tangible book value per share should not be considered in isolation or as a substitute for book value per share or total shareholders’ equity determined in accordance with GAAP, and may not be comparable to a similarly titled measure reported by other companies. Reconciliation of the GAAP and non-GAAP financial measures are presented below.

                   
    Balance Sheet              
    (Dollars in thousands, except per share data)       (Unaudited)  
                September 30, June 30, September 30,
                  2024     2024     2023  
                     
    Assets:              
      Cash and due from banks       $ 22,954   $ 22,361   $ 19,743  
      Interest bearing deposits in banks       19,035     1,401     1,040  
      Federal funds sold           200     –     –  
      Total cash and cash equivalents       42,189     23,762     20,783  
      Securities available-for-sale, at fair value       306,982     306,869     308,786  
      Federal Home Loan Bank (“FHLB”) stock       11,218     10,136     10,438  
      Federal Reserve Bank (“FRB”) stock       4,131     4,131     4,131  
      Mortgage loans held-for-sale, at fair value       13,429     10,518     17,880  
      Loans:              
      Real estate loans:            
      Residential 1-4 family         156,811     157,053     146,938  
      Residential 1-4 family construction       52,217     50,228     48,135  
      Commercial real estate         644,019     627,326     611,963  
      Commercial construction and development     125,323     137,427     151,614  
      Farmland           145,356     142,353     143,789  
      Other loans:              
      Home equity           93,646     93,213     83,221  
      Consumer           29,445     29,118     29,832  
      Commercial           143,190     143,641     129,952  
      Agricultural           144,645     137,134     130,329  
      Total loans           1,534,652     1,517,493     1,475,773  
      Allowance for credit losses         (17,130 )   (16,830 )   (16,230 )
      Net loans           1,517,522     1,500,663     1,459,543  
      Accrued interest and dividends receivable       14,844     13,195     13,657  
      Mortgage servicing rights, net         15,443     15,614     15,738  
      Assets held-for-sale, at cost         257     257     –  
      Premises and equipment, net         100,297     98,397     92,979  
      Cash surrender value of life insurance, net       52,852     48,529     47,647  
      Goodwill           34,740     34,740     34,740  
      Core deposit intangible, net         4,834     5,168     6,264  
      Other assets           26,375     26,976     30,478  
      Total assets         $ 2,145,113   $ 2,098,955   $ 2,063,064  
                     
    Liabilities:              
      Deposit accounts:              
      Noninterest bearing       $ 419,760   $ 400,113   $ 435,655  
      Interest bearing           1,230,752     1,218,752     1,179,823  
      Total deposits         1,650,512     1,618,865     1,615,478  
      Accrued expenses and other liabilities       38,593     35,804     31,597  
      FHLB advances and other borrowings       219,167     215,050     199,757  
      Other long-term debt, net         59,111     59,074     58,962  
      Total liabilities         1,967,383     1,928,793     1,905,794  
                     
    Shareholders’ Equity:              
      Preferred stock (par value $0.01 per share; 1,000,000 shares      
      authorized; no shares issued or outstanding)     –     –     –  
      Common stock (par value $0.01; 20,000,000 shares authorized;      
      8,507,429 shares issued; 8,016,784, 8,016,784 and 7,988,132      
      shares outstanding at September 30, 2024, June 30, 2024 and      
      September 30, 2023, respectively       85     85     85  
      Additional paid-in capital         109,040     108,962     109,422  
      Unallocated common stock held by Employee Stock Ownership Plan   (4,154 )   (4,297 )   (4,727 )
      Treasury stock, at cost (490,645, 490,645 and 519,297 shares at      
      September 30, 2024, June 30, 2024 and September 30, 2023, respectively)           (11,124 )   (11,124 )   (11,574 )
      Retained earnings           98,979     97,413     94,979  
      Accumulated other comprehensive loss, net of tax     (15,096 )   (20,877 )   (30,915 )
      Total shareholders’ equity       177,730     170,162     157,270  
      Total liabilities and shareholders’ equity   $ 2,145,113   $ 2,098,955   $ 2,063,064  
                     
    Income Statement      (Unaudited)   (Unaudited)
    (Dollars in thousands, except per share data)     Three Months Ended   Nine Months Ended
                  September 30, June 30, September 30,   September 30,
                    2024   2024   2023     2024   2023  
    Interest and dividend income:                
      Interest and fees on loans     $ 23,802 $ 22,782 $ 21,068   $ 68,526 $ 57,942  
      Securities available-for-sale       2,598   2,631   2,794     7,953   8,586  
      FRB and FHLB dividends       266   264   212     777   480  
      Other interest income       94   145   20     268   66  
        Total interest and dividend income       26,760   25,822   24,094     77,524   67,074  
    Interest expense:                  
      Interest expense on deposits       7,190   6,884   5,152     20,622   11,767  
      FHLB advances and other borrowings       3,084   2,625   2,672     8,206   5,993  
      Other long-term debt       684   681   683     2,048   2,035  
        Total interest expense       10,958   10,190   8,507     30,876   19,795  
    Net interest income         15,802   15,632   15,587     46,648   47,279  
    Provision for credit losses       277   412   588     554   1,186  
        Net interest income after provision for credit losses     15,525   15,220   14,999     46,094   46,093  
                             
    Noninterest income:                
      Service charges on deposit accounts       430   428   447     1,258   1,313  
      Mortgage banking, net       2,602   2,417   4,338     7,196   11,252  
      Interchange and ATM fees       662   640   643     1,865   1,861  
      Appreciation in cash surrender value of life insurance     1,038   320   382     1,646   1,165  
      Net loss on sale of available-for-sale securities       –   –   –     –   (222 )
      Other noninterest income       251   464   225     1,239   1,541  
        Total noninterest income       4,983   4,269   6,035     13,204   16,910  
                             
    Noninterest expense:                
      Salaries and employee benefits       9,894   10,273   10,837     29,885   31,614  
      Occupancy and equipment expense       2,134   2,104   1,956     6,337   6,100  
      Data processing       1,587   1,382   1,486     4,494   4,270  
      Advertising         277   316   340     846   930  
      Amortization         337   348   386     1,054   1,201  
      Loan costs         385   412   517     1,195   1,426  
      FDIC insurance premiums       295   284   301     878   862  
      Professional and examination fees       438   423   408     1,345   1,484  
      Other noninterest expense       1,923   1,765   1,644     5,576   5,311  
        Total noninterest expense       17,270   17,307   17,875     51,610   53,198  
                             
    Income before provision for income taxes       3,238   2,182   3,159     7,688   9,805  
    Provision for income taxes       529   444   524     1,343   1,913  
    Net income         $ 2,709 $ 1,738 $ 2,635   $ 6,345 $ 7,892  
                             
    Basic earnings per common share     $ 0.35 $ 0.22 $ 0.34   $ 0.81 $ 1.01  
    Diluted earnings per common share     $ 0.34 $ 0.22 $ 0.34   $ 0.81 $ 1.01  
                             
    Basic weighted average shares outstanding       7,836,921   7,830,925   7,784,279     7,830,947   7,787,987  
                             
    Diluted weighted average shares outstanding       7,860,138   7,845,272   7,791,966     7,848,196   7,792,593  
                             
    ADDITIONAL FINANCIAL INFORMATION   (Unaudited)  
    (Dollars in thousands, except per share data) Three or Nine Months Ended
          September 30, June 30, September 30,
            2024     2024     2023  
               
    Mortgage Banking Activity (For the quarter):      
      Net gain on sale of mortgage loans $ 1,691   $ 1,600   $ 3,591  
      Net change in fair value of loans held-for-sale and derivatives   159     12     (71 )
      Mortgage servicing income, net   752     805     818  
      Mortgage banking, net   $ 2,602   $ 2,417   $ 4,338  
               
    Mortgage Banking Activity (Year-to-date):      
      Net gain on sale of mortgage loans $ 4,705     $ 8,551  
      Net change in fair value of loans held-for-sale and derivatives   (2 )     234  
      Mortgage servicing income, net   2,493       2,467  
      Mortgage banking, net   $ 7,196     $ 11,252  
               
    Performance Ratios (For the quarter):      
      Return on average assets   0.51 %   0.33 %   0.51 %
      Return on average equity   6.56 %   4.30 %   6.63 %
      Yield on average interest earning assets   5.66 %   5.64 %   5.27 %
      Cost of funds     2.89 %   2.78 %   2.37 %
      Net interest margin   3.34 %   3.41 %   3.41 %
      Core efficiency ratio*   81.47 %   85.22 %   80.89 %
               
    Performance Ratios (Year-to-date):      
      Return on average assets   0.41 %     0.53 %
      Return on average equity   5.19 %     6.54 %
      Yield on average interest earning assets   5.59 %     5.07 %
      Cost of funds     2.78 %     1.94 %
      Net interest margin   3.36 %     3.57 %
      Core efficiency ratio*   84.47 %     81.01 %
               
    * The core efficiency ratio is a non-GAAP ratio that is calculated by dividing non-interest expense, exclusive of acquisition
    costs and intangible asset amortization, by the sum of net interest income and non-interest income.    
               
               
    ADDITIONAL FINANCIAL INFORMATION      
    (Dollars in thousands, except per share data)      
            (Unaudited)  
    Asset Quality Ratios and Data: As of or for the Three Months Ended
          September 30, June 30, September 30,
            2024     2024     2023  
               
      Nonaccrual loans   $ 3,859   $ 4,012   $ 7,753  
      Loans 90 days past due and still accruing   944     1,076     –  
      Total nonperforming loans     4,803     5,088     7,753  
      Other real estate owned and other repossessed assets   4     4     –  
      Total nonperforming assets   $ 4,807   $ 5,092   $ 7,753  
               
      Nonperforming loans / portfolio loans   0.31 %   0.34 %   0.53 %
      Nonperforming assets / assets   0.22 %   0.24 %   0.38 %
      Allowance for credit losses / portfolio loans   1.12 %   1.11 %   1.10 %
      Allowance for credit losses/ nonperforming loans   356.65 %   330.78 %   209.34 %
      Gross loan charge-offs for the quarter $ 22   $ 12   $ 122  
      Gross loan recoveries for the quarter $ 5   $ 10   $ 14  
      Net loan charge-offs for the quarter $ 17   $ 2   $ 108  
               
               
          September 30, June 30, September 30,
            2024     2024     2023  
    Capital Data (At quarter end):      
      Common shareholders’ equity (book value) per share $ 22.17   $ 21.23   $ 19.69  
      Tangible book value per share** $ 17.23   $ 16.25   $ 14.55  
      Shares outstanding   8,016,784     8,016,784     7,988,132  
      Tangible common equity to tangible assets***   6.56 %   6.33 %   5.75 %
               
    Other Information:        
      Average investment securities for the quarter $ 305,730   $ 306,207   $ 319,308  
      Average investment securities year-to-date $ 308,688   $ 310,168   $ 335,898  
      Average loans for the quarter **** $ 1,547,246   $ 1,513,313   $ 1,476,584  
      Average loans year-to-date **** $ 1,519,951   $ 1,506,303   $ 1,417,291  
      Average earning assets for the quarter $ 1,874,669   $ 1,837,418   $ 1,812,610  
      Average earning assets year-to-date $ 1,847,468   $ 1,833,867   $ 1,768,361  
      Average total assets for the quarter $ 2,116,839   $ 2,077,448   $ 2,052,443  
      Average total assets year-to-date $ 2,086,951   $ 2,072,013   $ 1,999,864  
      Average deposits for the quarter $ 1,622,254   $ 1,625,882   $ 1,602,770  
      Average deposits year-to-date $ 1,624,936   $ 1,625,826   $ 1,596,201  
      Average equity for the quarter $ 165,162   $ 161,533   $ 158,933  
      Average equity year-to-date $ 163,106   $ 162,084   $ 160,917  
               
    ** The tangible book value per share is a non-GAAP ratio that is calculated by dividing shareholders’ equity,  
    less goodwill and core deposit intangible, by common shares outstanding.      
    *** The tangible common equity to tangible assets is a non-GAAP ratio that is calculated by dividing shareholders’  
    equity, less goodwill and core deposit intangible, by total assets, less goodwill and core deposit intangible.  
    **** Includes loans held for sale      
           
    Reconciliation of Non-GAAP Financial Measures              
                           
    Core Efficiency Ratio     (Unaudited)     (Unaudited)  
    (Dollars in thousands)   Three Months Ended   Nine Months Ended  
              September 30, June 30, September 30,   September 30,  
                2024     2024     2023       2024     2023    
    Calculation of Core Efficiency Ratio:              
      Noninterest expense $ 17,270   $ 17,307   $ 17,875     $ 51,610   $ 53,198    
      Intangible asset amortization   (337 )   (348 )   (386 )     (1,054 )   (1,201 )  
        Core efficiency ratio numerator   16,933     16,959     17,489       50,556     51,997    
                           
      Net interest income   15,802     15,632     15,587       46,648     47,279    
      Noninterest income   4,983     4,269     6,035       13,204     16,910    
        Core efficiency ratio denominator   20,785     19,901     21,622       59,852     64,189    
                           
      Core efficiency ratio (non-GAAP)   81.47 %   85.22 %   80.89 %     84.47 %   81.01 %  
                           
    Tangible Book Value and Tangible Assets   (Unaudited)
    (Dollars in thousands, except per share data)   September 30, June 30, September 30,
                  2024     2024     2023  
    Tangible Book Value:            
      Shareholders’ equity     $ 177,730   $ 170,162   $ 157,270  
      Goodwill and core deposit intangible, net     (39,574 )   (39,908 )   (41,004 )
        Tangible common shareholders’ equity (non-GAAP) $ 138,156   $ 130,254   $ 116,266  
                     
      Common shares outstanding at end of period   8,016,784     8,016,784     7,988,132  
                     
      Common shareholders’ equity (book value) per share (GAAP) $ 22.17   $ 21.23   $ 19.69  
                     
      Tangible common shareholders’ equity (tangible book value)      
        per share (non-GAAP)     $ 17.23   $ 16.25   $ 14.55  
                     
    Tangible Assets:            
      Total assets       $ 2,145,113   $ 2,098,955   $ 2,063,064  
      Goodwill and core deposit intangible, net     (39,574 )   (39,908 )   (41,004 )
        Tangible assets (non-GAAP)   $ 2,105,539   $ 2,059,047   $ 2,022,060  
                     
      Tangible common shareholders’ equity to tangible assets      
        (non-GAAP)         6.56 %   6.33 %   5.75 %
                     
    Contacts: Laura F. Clark, President and CEO
      (406) 457-4007
      Miranda J. Spaulding, SVP and CFO
      (406) 441-5010  

    The MIL Network –

  • MIL-OSI Global: Four reasons weight-loss jabs alone won’t help get people back to work

    Source: The Conversation – UK – By Lucie Nield, Senior Lecturer in Nutrition and Dietetics, Sheffield Hallam University

    Weight-loss injectables don’t address the many core reasons for why weight gain and unemployment occur in the first place. oleschwander/ Shutterstock

    Prime Minister Keir Starmer and health secretary Wes Streeting have recently discussed plans to trial weight-loss injections for around 250,000 people with obesity who are unemployed in a bid to get them back into work, ease pressure on the NHS and boost the economy.

    Obesity is estimated to cost UK society around £35 billion annually. This is due to lower productivity and higher NHS treatment costs.

    Around 26% of the English adult population (approximately 15 million) are considered obese. However, it’s not known what proportion of unemployed people are obese.

    While weight-loss injections have proven to be very effective in helping people who are obese to lose weight and lower their risk of certain chronic diseases, there are many reasons why these drugs alone won’t help tackle obesity and unemployment rates in the UK.

    1. Lack of capacity

    The majority of UK people who are obese are likely to meet the National Institute for Health and Care Excellence’s eligibility criteria for weight-loss injections.

    But prescribing these drugs is just one part of the equation. Eligible patients will require support from specialist services who provide guidance in making the appropriate lifestyle changes (such as to their diet) to successfully lose weight while on these drugs. This is crucial, as all of the weight-loss injection trials to date have involved a behaviour change component. This may potentially be key to the successful weight losses observed in these studies.

    However, current demand for weight-loss services is already outstripping capacity. Nearly half of eligible patients in England are unable to get an appointment with a specialist team. Weight-loss injections can only be prescribed through such services currently. If the government is to roll out the proposed programme, they will need to rethink the way weight-loss services are delivered so all eligible patients can access support.

    2. Won’t work for everyone

    Weight-loss jabs don’t necessarily work for everyone. One study found that 9-15% of participants who took the drug tirzepatide (Mounjaro) did not lose clinically significant amounts of weight.

    Weight-loss jabs may also cause intolerable side-effects for some. Trials have shown between 4-8% of participants couldn’t tolerate the side-effects, causing them to drop out of the study. Constipation, diarrhoea and nausea are some of the most commonly reported.

    People with certain health conditions may be unable to use weight-loss injections – such as those with inflammatory bowel disease and pancreatitis. In such cases, weight-loss jabs may worsen symptoms or interact with the prescription drugs used to manage these conditions, increasing risk of harm.

    There are many reasons why weight-loss jabs may not work for a person.
    Douglas Cliff/ Shutterstock

    Additionally, some people may not want to take an injection – whether that’s simply due to personal preference or even fear of needles.

    3. Obesity is a complex issue

    There are many complex factors that contribute to weight gain – such as opportunities for physical activity, access to healthy foods and levels of deprivation in a community. Prescribing weight-loss jabs to help people lose weight may not be effective long-term if the rest of these factors are not also addressed.

    A more effective way of seeing significant, sustainable reductions in obesity levels across a population is by using a “whole systems approach”. This would address to the multiple environmental, social and economic factors that contribute to obesity.

    Where whole systems approaches have been embedded in healthcare design and delivery, they have led to improvements in services and patient outcomes – including obesity-related metrics (such as patients making healthier food choices and being more active).

    However, one limitation to whole systems approaches is challenges in measuring impact. This can reduce political will to implement these approaches.

    4. Obesity stigma

    Obesity stigma in the workplace is a huge barrier to satisfactory employment and leads to poor wellbeing and burnout.

    Obesity stigma in the workplace perpetuates harmful weight-based stereotypes that overweight and obese people are lazy, unsuccessful, unintelligent and lack willpower. As a result, people with obesity are more likely to be in insecure and lower-paid jobs than those who may be considered of a healthy weight.

    It’s also well-evidenced that regular exposure to stigmatising, isolating and degrading prejudices has long-term consequences on physical and mental health – and may lead to problems such as binge eating and depression.This can lead to a loss of productivity, absenteeism and loneliness.

    Prescribing weight-loss jabs to help a person lose weight doesn’t address the core reasons for why they may have been absent from work or unemployed in the first place. Nor does it help to address the mental health struggles they may still harbour as a result of discrimination they might have experienced.

    5. Barriers to employment

    Weight loss alone does not begin to address the complex physical and mental health reasons for why a person might be unemployed. A person may also be unemployed due to factors such as caring responsibilities or disability.

    Current prescribing restrictions also limit some injections to a maximum of 24 months (although further trials are ongoing). This means that even if a person has successfully lost weight, they may regain that weight again when they stop using the drug. This could mean any health problems they experienced prior to losing weight (and which may have prevented them from being in employment) could reemerge.

    There are better ways of getting people back into work than prescribing weight-loss jabs. Flexible working approaches, for instance, may make it easier for someone who is unemployed due to caring responsibilities or health problems to transition back into employment. Supportive policies and workplace wellbeing programmes may be a more cost-effective way of helping people to overcome barriers, improve their health and transition back into work.

    Lucie Nield has received funding from The National Institute for Health Research (NIHR) for evaluation of children’s weight management services.

    Lucie Nield sits on the Board of Trustees for Darnall Wellbeing (a local community service organisation).

    – ref. Four reasons weight-loss jabs alone won’t help get people back to work – https://theconversation.com/four-reasons-weight-loss-jabs-alone-wont-help-get-people-back-to-work-241835

    MIL OSI – Global Reports –

  • MIL-OSI Global: The ancient Irish get far too much credit for Halloween

    Source: The Conversation – USA – By Lisa Bitel, Dean’s Professor of Religion & Professor of History, USC Dornsife College of Letters, Arts and Sciences

    The Celtic festival of Samhain celebrates a time of year when the division between Earth and the otherworld collapses, allowing spirits to pass through. Matt Cardy/Getty Images

    This time of year, I often run across articles proclaiming Halloween a modern form of the pagan Irish holiday of Samhain – pronounced SAW-en. But as a historian of Ireland and its medieval literature, I can tell you: Samhain is Irish. Halloween isn’t.

    The Irish often get credit – or blame – for the bonfires, pranksters, witches, jack-o’-lanterns and beggars who wander from house to house, threatening tricks and soliciting treats.

    The first professional 19th-century folklorists were the ones who created a through line from Samhain to Halloween. Oxford University’s John Rhys and James Frazer of the University of Cambridge were keen to find the origins of their national cultures.

    They observed lingering customs in rural areas of Britain and Ireland and searched medieval texts for evidence that these practices and beliefs had ancient pagan roots. They mixed stories of magic and paganism with harvest festivals and whispers of human sacrifice, and you can still find echoes of their outdated theories on websites.

    But the Halloween we celebrate today has more to do with the English, a ninth-century pope and America’s obsession with consumerism.

    A changing of the seasons

    For two millennia, Samhain, the night of Oct. 31, has marked the turn from summer to winter on the Irish calendar. It was one of four seasonal signposts in agricultural and pastoral societies.

    After Samhain, people brought the animals inside as refuge from the long, cold nights of winter. Imbolc, which is on Feb. 1, marked the beginning of the lambing season, followed by spring planting. Beltaine signaled the start of mating season for humans and beasts alike on May 1, and Lughnasadh kicked off the harvest on Aug. 1.

    But whatever the ancient Irish did on Oct. 31 is lost to scholars because there’s almost no evidence of their pagan traditions except legends written by churchmen around 800 A.D., about 400 years after the Irish started turning Christian. Although they wrote about the adventures of their ancestors, churchmen could only imagine the pagan ways that had disappeared.

    A neopagan celebration of Samhain in October 2021.
    Wikimedia Commons, CC BY-SA

    An otherworld more utopian than terrifying

    These stories about the pagan past told of Irish kings holding annual weeklong feasts, markets and games at Samhain. The day ended early in northwestern Europe, before 5 p.m., and winter nights were long. After sundown, people went inside to eat, drink and listen to storytellers.

    The stories did not link Samhain with death and horror. But they did treat Samhain as a night of magic, when the otherworld – what, in Irish, was known as the “sí” – opened its portals to mortals. One tale, “The Adventure of Nera,” warned that if you went out on Samhain Eve, you might meet dead men or warriors from the sí, or you might unknowingly wander into the otherworld.

    When Nera went out on a dare, he met a thirsty corpse in search of drink and unwittingly followed warriors through a portal into the otherworld. But instead of ghosts and terror, Nera found love. He ended up marrying a “ban sídh” – pronounced “BAN-shee” – an otherworldly woman. But here’s the medieval twist to the tale: He lived happily ever after in this otherworld with his family and farm.

    The Irish otherworld was no hell, either. In medieval tales, it is a sunny place in perpetual spring. Everyone who lives there is beautiful, powerful, immortal and blond. They have good teeth. The rivers flow with mead and wine, and food appears on command. No sexual act is a sin. The houses sparkle with gems and precious metals. Even the horses are perfect.

    Clampdown on pagan customs

    The link between Oct. 31, ghosts and devils was really the pope’s fault.

    In 834, Pope Gregory IV decreed Nov. 1 the day for celebrating all Christian saints. In English, the feast day became All Hallows Day. The night before – Oct. 31 – became known as All Hallows Eve.

    Some modern interpretations insist that Pope Gregory created All Hallows Day to quell pagan celebrations of Samhain. But Gregory knew nothing of ancient Irish seasonal holidays. In reality, he probably did it because everyone celebrated All Saints on different days and, like other Popes, Gregory sought to consolidate and control the liturgical calendar.

    In the later Middle Ages, All Hallows Eve emerged as a popular celebration of the saints. People went to church and prayed to the saints for favors and blessings. Afterward, they went home to feast. Then, on Nov. 2, they celebrated All Souls’ Day by praying for the souls of their lost loved ones, hoping that prayers would help their dead relatives out of purgatory and into heaven.

    But in the 16th century, the Protestant rulers of Britain and Ireland quashed saints’ feast days, because praying to saints seemed idolatrous. Protestant ministers did their best to eliminate popular customs of the early November holidays, such as candle-lit processions and harvest bonfires.

    In the minds of ministers, these customs smacked of heathenism.

    A mishmash of traditions

    Our Halloween of costumed beggars and leering jack-o’-lanterns descends from this mess of traditions, storytelling and antiquarianism.

    Like our ancestors, we constantly remake our most important holidays to suit current culture.

    Jack-o’-lanterns are neither ancient nor Irish. One of the earliest references is an 18th-century account of an eponymous Jack, who tricked the devil one too many times and was condemned to wander the world forever.

    Supposedly, Jack, or whatever the hero was called, carved a turnip and stuck a candle in it as his lantern. But the custom of carving turnips in early November probably originated in England with celebrations of All Saints’ Day and another holiday, Guy Fawkes Day on Nov. 5, with its bonfires and fireworks, and it spread from there.

    Guy Fawkes Day, an annual celebration in Great Britain, features fireworks and bonfires and is observed on Nov. 5.
    Hulton-Deutsch Collection/Corbis via Getty Images

    As for ancient bonfires, the Irish and Britons built them to celebrate Beltaine, but not Samhain – at least, not according to the medieval tales.

    In 19th-century Ireland, All Hallows Eve was a time for communal suppers, games like bobbing for apples and celebrating the magic of courtship. For instance, girls tried to peel apples in one long peel; then they examined the peels to see what letters they resembled – the initials of their future husbands’ names. Boys crept out of the gathering, despite warnings, to make mischief, taking off farm gates or stealing cabbages and hurling them at the neighbors’ doors.

    Halloween with an American sheen

    Across the Atlantic, these customs first appeared in the mid-19th century, when the Irish, English and many other immigrant groups brought their holidays to the U.S.

    In medieval Scotland, “guisers” were people who dressed in disguise and begged for “soul cakes” on All Souls Day. These guisers probably became the costumed children who threatened – and sometimes perpetrated – mischief unless given treats. Meanwhile, carved turnips became jack-o’-lanterns, since pumpkins were plentiful in North America – and easier to carve.

    Like Christmas, Valentine’s Day and Easter, Halloween eventually became a feast of consumerism. Companies mass-produced costumes, paper decorations and packaged candy. People in Britain and Ireland blamed the Americans for the spread of modern Halloween and its customs. British schools even tried to quash the holiday in the 1990s because of its disorderly and demonic connotations.

    The only real remnant of Samhain in Halloween is the date. Nowadays, no one expects to stumble into a romance in the sí. Only those drawn to the ancient Celtic past sense the numinous opening of the otherworld at Samhain.

    But who’s to say which reality prevails when the portals swing open in the dark of Oct. 31?

    Lisa Bitel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. The ancient Irish get far too much credit for Halloween – https://theconversation.com/the-ancient-irish-get-far-too-much-credit-for-halloween-239801

    MIL OSI – Global Reports –

  • MIL-OSI NGOs: Israeli UNRWA ban will deepen Palestinian humanitarian catastrophe

    Source: Médecins Sans Frontières –

    The Israeli Knesset’s (parliament’s) ban on UNRWA’s operations voted on 28 October represents a devastating blow to Palestinian life. It will further undermine people’s survival prospects in Gaza and heavily impact communities in the West Bank.

    Médecins Sans Frontières (MSF) denounces this legislation, which represents an inhumane ban on vital humanitarian aid. The Knesset’s vote is propelling Palestinians towards an even deeper humanitarian crisis. It is imperative that the world acts to safeguard Palestinians’ fundamental rights. Immediate international intervention is needed to pressure Israel to allow unhindered access to humanitarian aid, implement a ceasefire, and bring to an end the current campaign of destruction in Gaza.

    “UNRWA is a lifeline for Palestinians,” says Christopher Lockyear, MSF Secretary General. “If implemented, the ban on UNRWA’s activities would have catastrophic implications on the dire humanitarian situation of Palestinians living in Gaza, as well as in the West Bank, now and for generations to come. We strongly condemn this decision, which is the culmination of a long-running campaign against the organisation.”

    The newly voted legislation will make it almost impossible for UNRWA to work in Gaza or the West Bank; coordination with Israeli authorities will be impeded and entrance permits to either of the occupied territories will be denied, and essentially blocking delivery of UNRWA aid into and within Gaza. UNRWA handles almost all the distribution of UN aid coming into the strip.

    UNRWA is the largest health provider in Gaza, with over half of Gazans relying on UNWRA for essential healthcare services, including for the treatment of chronic diseases, maternal and child heath, and vaccinations. Each day UNWRA’s health teams provide over 15,000 consultations in the Gaza Strip. The ban of its activities threatens to create a vast gap in services within an already largely destroyed health system in Gaza – directly and indirectly endangering the lives of Palestinians. Without urgent action, more Gazans could die from preventable diseases and displacement-related conditions.

    The impact of UNRWA’s ban will extend beyond Gaza. Critical services, including refugee camp management, health services, education, and social programmes across the West Bank are also at risk of destabilisation under this legislation. This legislation sets a grave precedent for other conflict situations where governments may wish to eliminate an inconvenient United Nations presence.

    For months, international leaders and organisations, including MSF, have raised warnings about the disastrous potential of these newly adopted bills. Yet Israel has chosen to press forward with measures that will undermine vital assistance, endangering Palestinian lives and intensifying the collective punishment they face.

    This vote adds to the endless physical and bureaucratic impediments imposed by Israel to limit the amount of aid reaching Gaza, and blatantly contradicts Israel’s claims that it is facilitating humanitarian assistance into the Strip.

    MIL OSI NGO –

  • MIL-OSI United Kingdom: There is no justification for denying civilians in Gaza access to life-saving aid: UK statement at the UN Security Council

    Source: United Kingdom – Executive Government & Departments

    Statement by Ambassador Barbara Woodward, UK Permanent Representative to the UN, at the UN Security Council open debate on the situation in the Middle East.

    Location:
    United Nations, New York
    Delivered on:
    (Transcript of the speech, exactly as it was delivered)

    President, the death of Hamas’ leader, who had the blood of innocent Israelis and Palestinians on his hand, must be a turning point in this dreadful conflict, which has now claimed over 43,000 lives in Gaza. 

    This is the time to urgently seize a ceasefire in Gaza and the immediate and unconditional release of all hostages who have suffered in inhumane conditions for over a year.

    The humanitarian situation in Gaza is horrific. Acute malnutrition is now a reality for many. This month, the least aid has entered Gaza since the beginning of the conflict. 

    And the situation in northern Gaza is especially alarming. Gazans have been asked to evacuate the north in their hundreds of thousands. But there is nowhere safe to go. In recent weeks, just as we have seen throughout the conflict, Israeli strikes have hit designated humanitarian zones.

    On Thursday, we saw again profoundly distressing scenes after an Israeli strike on Al-Shuhada – a school-turned shelter in Nuseirat refugee camp, which killed at least 17 people, including nine children.  

    We remain very concerned too about the severe impacts of these strikes on civilian infrastructure, including healthcare facilities, which face critical shortages in medical supplies, food and water. Israel must comply fully with international humanitarian law. As my Prime Minister has said, the world will not tolerate any more excuses from Israel on humanitarian assistance. 

    There is no justification for denying civilians access to essential supplies. The Government of Israel must do more to protect civilians, civilian infrastructure, and allow aid to be delivered safely and at scale. Related to this, reports that UN agencies have had to postpone the rollout of the polio vaccine campaign in northern Gaza are deeply disturbing. Israeli authorities must allow aid workers to carry out this work safely and securely.

    We also unequivocally reject attempts to undermine or degrade UNRWA, which is the backbone of the humanitarian response in Gaza and a lifeline for hundreds of thousands of civilians there, and in the wider region. The allegations against UNRWA staff earlier this year were fully investigated. There is no justification for cutting off ties with UNRWA. Israel must abide by its obligations and ensure UNRWA can continue its lifesaving work. 

    President, we reiterate that northern Gaza must not be cut off from the south. Palestinian civilians, including those evacuated from northern Gaza must be permitted to return. There must be no forcible transfer of Gazans from or within Gaza, nor any reduction in the territory of the Gaza Strip. Civilians must be protected.

    In the West Bank, the level of llegal settlement expansion and settler violence is unprecedented. Israel must take action now to address this.  

    President, a sustainable solution to this crisis cannot and will not be achieved through unilateral action. The international community and this Council have been clear and unified in our commitment to the two state solution, which is the only viable path to a long term peaceful solution. 

     The Palestinian and Israeli people alike have a right to self-determination, safety and security, and we must all work together to provide a credible and irreversible pathway towards a two-state solution.

    Updates to this page

    Published 29 October 2024

    MIL OSI United Kingdom –